| Product |
Cat. # |
Stand. Range / Sensitivity |
Specimen |
Test Type |
Units |
| Acetylchloline Receptor
(AChR) Ab Elisa |
EIA4936 |
0.5- 20 nmol/l
/// 0.23 nmol./l |
100 ul serum |
Quant |
96 wells |
| ACPA
(Anti-Citrullinated Protein Ab) (Anti-MCV) Elisa |
EIA4848 |
10 - 500 U/ml /// 2 U/mo |
10 ul serum, plasma |
Quant |
96 wells |
| ACTH
(Adrenocorticotropic Hormone) |
EIA3647 |
.46pg/mL |
human serum |
Quant |
96 wells |
| Adenovirus
IgA |
EIA3445 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Adenovirus
IgG |
EIA3446 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Adenovirus
IgM |
EIA3447 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Adenovirus-FL&K87
(mouse) EcoElisa |
EIA4946 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Adenovirus-FL&K87
(mouse) EcoElisa |
EIA4947 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Adenovirus-FL&K87
(rat) EcoElisa |
EIA4948 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Adenovirus-FL&K87
(rat) EcoElisa |
EIA4949 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Adipocyte
FABP (AFABP, FABP4) human Elisa |
EIA4908 |
0.5 - 25 ng/ml ///
<0.1 ng/ml |
20 ul serum, plasma |
Quant |
96 wells |
| Adiponectin
(human) Elisa |
EIA4177 |
1.56 - 200 ng/ml // 0.78 ng/ml |
20 ul serum, plasma,
tissuesculture media |
Quant |
96 wells |
| Adiponectin
(human) Elisa |
EIA4574 |
0.1 - 10 ug/ml //
7 ng/ml |
10 ul serum / plasma |
Quant |
96 wells |
| Adiponectin
(human) Elisa |
EIA4646 |
5 - 300 ng/ml ///
1.25 ng/ml |
25 ul serum / plasma |
Quant |
96 wells |
| Adiponectin
(human) Elisa |
EIA4820 |
1.56 - 100 ng/ml ///
<3 ng/ml |
5-10 ul cell culture supernat,
plasma, serum |
Quant |
96 wells |
| Adiponectin (human) high
molecular weight (HMW) |
EIA4645 |
1.56 ng/ml to 200 ng/ml
/// 0.5 ng/ml |
20 ul serum, plasma, and adipocyte extracts |
Quant |
96 wells |
| Adiponectin
(mouse) Elisa |
EIA4172 |
0.78 - 100 ng/ml // 0.5 ng/ml |
10 ul serum, plasma, tissue
culture media |
Quant |
96 wells |
| Adiponectin
Rat Elisa |
EIA4570 |
3.125- 200 ng/ml //
0.155 ng/ml |
20 ul serum, plasma, nd adipocyte
extracts |
Quant |
96 wells |
| Adrenalin
Research Elisa |
EIA4776 |
5 - 1280 pg/sample //
1.7 pg/sample |
1-100 ul, tissues extracts,
dialysates |
Quant |
96 wells |
| Adrenaline
(Epinephrine) |
EIA1908 |
1,4-150 ng/ml |
75 ul urine/ Extr. & Acylat |
Quant |
96 wells |
| Adrenaline
/ Noradrenaline (Cat Combi Elisa) |
EIA4309 |
Epine 1-256ng/ml, Norepine
0/1-1,024ng |
plasma and urine |
Quant |
2 x 96 wells |
| Adrenaline
Elisa |
EIA4306 |
1-256 pg/ml,0.33ng/mL
urine,11pg/mL plas |
10ul urine / 300 ul plasma |
Quant |
96 wells |
| Adrenomedullin,
(human) (1-52) |
EIA3418 |
|
|
Quant |
96 wells |
| Adrenomedullin,
(Pro-) N20 (PAMP-20) (human) |
EIA3419 |
|
|
Quant |
96 wells |
| Afamin
Elisa |
EIA5085 |
/// 0.01 mg/L |
serum / plasma |
Quant |
96 wells |
| AFP
(Alpha Fetoprotein) |
EIA1468 |
10-160 ng/ml |
serum, amino fluid |
Quant |
96 wells |
| AFP
(Alpha Fetoprotein) - extended Standard Range |
EIA4331 |
2.0 ng/ml |
serum |
Quant |
96 wells |
| Akt
(total), (human, mouse, rat) |
EIA3996 |
0.3 - 20 ng/ml / 0.1 ng/ml |
100 ul cell extract |
Quant |
96 tests |
| Akt
[pS473], (human, mouse, rat) |
EIA3997 |
1.6 - 100 U/ml /
0.8U/ml |
100 ul cell extract |
Quant |
96 tests |
| Aldosterone |
CLA4650 |
20 - 2000 pg/m //
10 pg/ml |
50 ul serum |
Quant |
96 wells |
| Aldosterone
Elisa |
EIA4410 |
20 - 2000 pg/ml //
15 pg/ml |
50 ul serum / plasma |
Quant |
96 wells |
| Aldosterone
Elisa |
EIA4600 |
20-2000 pg/ml //
15 pg/ml |
50 ul serum + urine |
Quant |
96 wells |
| Aldosterone,
direct (order urine diluent seperate) |
EIA4128 |
15 - 1000 pg/ml // 10 pg/ml |
50 ul serum or diluted urine |
Quant |
96 wells |
| AMA-M2 Elisa |
EIA3604 |
|
|
Quant |
96 wells |
| Amphetamine (must request controls with order) |
EIA1493 |
|
serum, plasma, blood |
Quant |
96 wells |
| Amylase
Elisa |
EIA4460 |
10 - 300 U/L //
6 U/L |
10 uL serum |
Quant |
96 wells |
| Amylin
(total) Elisa |
EIA3741 |
0-100pM / 1 pM |
50 ul plasma |
Quant |
96 wells |
| Amylin
Elisa |
EIA3742 |
0-100pM / 1pM |
50 ul plasma |
Quant |
96 wells |
| Amyloid
beta 1-40 (colometric) |
COL3994 |
|
|
Quant |
96 tests |
| Amyloid
beta 1-42 (colometric) |
COL3995 |
|
|
Quant |
96 tests |
| Amyloid
Beta Auto-Ab (serum) Elisa |
EIA5099 |
1 - 120 RTU ///
<1 RTU |
20 ul serum |
Quant |
96 wells |
| ANA
(Anti-Nuclear Antibodies) |
EIA4830 |
... ///
95 % |
10 ul serum |
Quant |
96 wells |
| ANA
Screen IgG (anti-nuclear antibodies) |
EIA2773 |
|
serum, 10 uL |
Qual |
96 wells |
| ANA-8-Profile
Elisa |
EIA3563 |
|
|
Quant |
96 wells |
| ANA-8-Profile
Elisa |
EIA4325 |
neg., pos. control //
<0.2 |
10 ul serum (diluted 1/100) |
Qual |
96 wells |
| ANA-8-Screen
Elisa |
EIA3562 |
|
|
Quant |
96 wells |
| ANCA
(cANCA) anti-PR3 |
EIA3596 |
|
|
Quant |
96 wells |
| ANCA
combi "ANCA Profil" Elisa |
EIA3595 |
|
|
Quant |
96 wells |
| ANCA
Screen Elisa |
EIA3776 |
qualitative, cut-off control |
serum or plasma 10 ul |
Qual |
96 wells |
| ANCA
Screen IgG |
EIA2777 |
|
serum, 10uL |
Qual |
96 wells |
| Androstane,
5a-Androstane-3a, 17beta-diol Glucuronide |
EIA4192 |
0.25 - 50 ng/ml // 0,1 ng/ml |
50 ul serum |
Quant |
96 wells |
| Androstenedione
Elisa |
EIA3265 |
|
|
|
96 wells |
| Androstenedione
Elisa |
EIA5050 |
0.1 - 10 ng/ml ///
0.04 ng/ml |
25 ul serum, plasma |
Quant |
96 wells |
| Androstenedione
Saliva |
EIA4347 |
5 - 1000 pg/ml //
1pg/ml |
100 ul Saliva |
Quant |
96 wells |
| Androstenedione
Saliva Elisa |
SLV4780 |
20 - 1000 pg/mL ///
5 pg/mL |
50 uL Saliva |
Quant |
96 wells |
| Angiotensin
1 |
EIA1638 |
0.1 ng/ml |
plasma |
Quant |
96 wells |
| Angiotensin
2 |
EIA1526 |
0.2ng/mL |
|
Quant |
96 wells |
| Animal
Insulin Control (3 vials /ea.0.5ml) |
CTL4784 |
|
|
|
1 vial |
| Annexin
V IgG/IgM, anti- |
EIA3971 |
6.3 - 100 U/ml //
1 U/ml |
10 ul serum or plasma |
Quant |
96 wells |
| ANP,
alpha- (human) (Atrial Natriuretic Polypeptide ) |
EIA1524 |
0.2 ng/mL |
|
Quant |
96 wells |
| Anti-Intrinsic
Factor Elisa |
EIA4392 |
6.3 - 100 U/mll //
1 U/ml |
10 ul serum / plasma |
Quant |
96 wells |
| APO 1
(Apolipoprotein) /FAS/ CD05 (FAS) |
EIA3875 |
0.23-15ng/mL < 20 pg/mL |
100 ul serum |
Quant |
96 wells |
| APO A
(Apolipoprotein) |
EIA1907 |
0.36-6.0 U/L |
25 ul serum |
Quant |
96 wells |
| ASCA IgG, Elisa |
EIA4280 |
20 - 300 U/ml // 10 U/ml |
10 ul serum (1:51 diluted) |
Quant |
96 wells |
| ASCA
combi Elisa |
EIA4278 |
compare w. pos. control) // |
10 ul serum (1:51 diluted) |
Qual |
96 wells |
| ASCA IgA
Elisa |
EIA4279 |
20-300 U/ml // 10 U/ml |
10 ul serum (1:51 diluted) |
Quant |
96 wells |
| ASGPR -
Anti-ASGPR Elisa |
EIA4271 |
pos. / neg. and cut off
control // 0.3 (ratio) |
10 ul serum, plasma (1:51
diluted) |
Qual |
96 wells |
| Aspergillus
fumigatus IgA |
EIA2500 |
|
|
|
96 wells |
| Aspergillus
fumigatus IgG |
EIA2501 |
1-200 U/mL //
/ |
5 ul serum, plasma |
Quant |
96 wells |
| Aspergillus
fumigatus IgM |
EIA2502 |
|
|
|
96 wells |
| Astrovirus
Ag (stool) Elisa |
EIA4456 |
pos./neg. control //
96% |
stool specimen |
Qual |
96 wells |
| Avian
Influenza A Nucleoprotein Ag Capture |
EIA4711 |
pos + neg control /// <90%- ///
<89% |
200 ul of complex sample matrices |
Qual |
2 x 96 wells |
| Avian
Influenza A Nucleoprotein Ag Capture |
EIA4713 |
pos + neg control ///
<90% |
200 ul of complex sample matrices |
Qual |
5 x 96 wells |
| Avian
Leukosis Virus-p27 antigen |
EIA2499 |
Positive and Negative Control |
100 ul egg or serum (1:1 diluted) |
|
96 wells |
| Barbiturates |
EIA1494 |
|
serum, plasma, blood |
Qual |
96 wells |
| Bax,
human Bax Elisa, (Bcl1 associated x protein) |
EIA4487 |
62.5 - 2,000 pg/mL //
10.1 pg/mL |
10 uL total cell lysates |
Quant |
96 wells |
| Bcl-2, human Bcl-2 Elisa (B-cell lymphoma 2) |
EIA4488 |
18.8 - 1,200 pg/mL //
3.8 pg/mL |
100 uL total cell lysates |
Quant |
96 wells |
| BLV
(Bovine Leukemea Virus) p24 blockin AB, MCA based |
EIA3159 |
|
|
|
96 wells |
| BLV
(Bovine Leukemia Virus) p24/gp51 antibodies (milk) |
EIA2496 |
Positive and Negative Control |
100 ul milk (undiluted) |
|
96 wells |
| BLV
(Bovine Leukemia Virus) p24/gp51 antibodies (serum) |
EIA2495 |
Positive and Negative Control |
100 ul Serum (1:20 diluted) |
|
96 wells |
| BNP-32,
(rat) (Brain Natriuretic Peptide) EIA |
EIA3428 |
|
|
Quant |
96 wells |
| Bordetella
pertussis IgA / toxin |
EIA3449 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Bordetella
pertussis IgG / toxin |
EIA3450 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Bordetella
pertussis IgM / toxin |
EIA3451 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Borrelia
burgdorferi Canine Ab Elisa |
EIA4794 |
neg. / pos. control |
serum and plasma |
Qual |
96 wells |
| Borrelia
burgdorferi IgG (Lyme) ( ref. sera opt) |
EIA2810 |
|
serum: 10uL |
Qual |
96 wells |
| Borrelia
burgdorferi IgG Elisa |
EIA4486 |
pos. / neg. control // 95 % |
10 ul serum |
Qual |
96 wells |
| Borrelia
burgdorferi IgG/IgM (Lyme ) (ref. sera opt) |
EIA2809 |
|
serum: 10uL |
Qual |
96 wells |
| Borrelia
burgdorferi IgM (Lyme ) (ref. sera opt) |
EIA2811 |
|
serum: 10uL |
Qual |
96 wells |
| Borrelia
burgdorferi IgM Elisa |
EIA4485 |
pos. / neg control /
90 % |
10 ul serum |
Qual |
96 wells |
| Borrelia
IgG Elisa (recombinant) |
EIA4289 |
pos. / neg, cut-off control |
10 ul serum (diluted 1:101) |
Qual |
96 wells |
| Borrelia
IgM Elisa (recombinant) |
EIA4288 |
pos. / neg cut-off control |
10 ul serum (diluted 1:101) |
Qual |
96 wells |
| BPI,
anti- Elisa |
EIA3598 |
|
|
Quant |
96 wells |
| Bradykinin
(human - rat - mouse) |
EIA1639 |
0.05 ng/ml |
plasma |
Quant |
96 wells |
| Brucella
Ab, cattle |
EIA2497 |
Positive and Negative Control |
|
|
96 wells |
| Brucella
IgA (human) min. order 5 kits |
EIA3271 |
1 - 200 U/ml |
100 ul serum, plasma (1:100
diluted) |
Quant |
96 wells |
| Brucella
IgG |
EIA3455 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Brucella
IgM |
EIA3456 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Buprenorphine (Request controls with order) |
EIA1498 |
n/a |
serum, plasma, blood |
Quant |
96 wells |
| C1q CIC
Elisa |
EIA3169 |
2 Standards ( h/l), concentration
: 16y/ml |
100 ul diluted Serum, Plasma |
Quant |
96 wells |
| C3bi CIC |
EIA3990 |
0-64 ug/ml /
2ug/ml |
10 ul serum |
Quant |
96 wells |
| C3d CIC
Elisa |
EIA3170 |
2 Standards (h/l), human
aggregate IgG |
100 ul diluted Serum, Plasma |
Quant |
96 wells |
| C3d
Elisa |
EIA2333 |
2 standards ( low and high) 2
controls |
100 ul serum (1:5 diluted) |
|
96 wells |
| C5a
(Anaphylatoxin/Complement Component) EIA |
EIA3327 |
Standard range: 0.1 - 10ug/L |
human plasma or urine |
Quant |
192 wells |
| CA 125 |
EIA3939 |
15 - 200 U/ml //
3.327 U/ml |
50 ul serum, plasma |
Quant |
96 wells |
| CA 125
(Ovarian Cancer) Antigen |
EIA1472 |
5 U/ml |
serum |
Quant |
96 wells |
| CA 15-3 |
EIA3941 |
25-200 U/ml //
0.905 U/ml |
10 ul serum, plasma |
Quant |
96 wells |
| CA 15-3
(Breast Cancer) Antigen (BCA) |
EIA1473 |
5 U/ml |
serum |
Quant |
96 wells |
| CA 19-9 |
EIA3940 |
15-240 U/ml /
0.888 U/ml |
10 ul serum, plasma |
Quant |
96 wells |
| CA 19-9
(Gastrointestinal Cancer) Antigen (GCA) |
EIA1474 |
5 U/ml |
serum |
Quant |
96 wells |
| CA 242 |
EIA2082 |
|
|
Quant |
96 wells |
| CA 72-4 |
CLA4730 |
|
|
Quant |
96 wells |
| CA 72-4 |
EIA3942 |
3-100 U/ml // < 0.311 |
20 ul serum, plasma |
Quant |
96 wells |
| CA-242
Elisa - Pancreatic-colo-rectal |
EIA4581 |
5 - 200 U/ml //
1 U/ml |
25 ul serum |
Quant |
96 wells |
| CagA |
EIA4138 |
0-240 RU/ml //sensit vs Western
Blot:93.7 % |
100 ul serum (1:300 diluted) |
Qual |
96 wells |
| Calcitonin |
EIA3648 |
1 pg / mL |
human serum |
Quant |
96 wells |
| Calcitonin
(salmon) |
EIA1636 |
0.2 ng/ml |
plasma |
Quant |
96 wells |
| Calcitonin
Gene Related Peptide (CGRP)(Human) - EIA Kit |
EIA4513 |
0 - 100 ng/ml //
0.23 ng/ml |
50 ul plasma |
Quant |
96 wells |
| Calprotectin
(MRP 8/14) Elisa |
EIA4498 |
3.9 250 ng/ml //
2.9 ng/ml |
100 ul serum ( 1:50 dil.); urine
(1:10 dil.) |
Quant |
96 wells |
| Candida
albicans IgA |
EIA3457 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
SemiQuant |
96 wells |
| Candida
albicans IgG |
EIA3458 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Candida
albicans IgM |
EIA3459 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Canine
FSH Elisa |
EIA4536 |
0.78 - 25 ng/ml //
0.21 ng/ml |
25 ul serum / plasma |
Quant |
96 wells |
| Carbacillu
(rat) EcoElisa |
EIA4950 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Carbacillu
(rat) EcoElisa |
EIA4951 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Cardiolipin
IgA (ref. sera optional, price on req.) |
EIA2790 |
|
serum, 10uL |
SemiQuant |
96 wells |
| Cardiolipin
IgG (ref. sera optional, price on req.) |
EIA2788 |
|
serum, 10uL |
SemiQuant |
96 wells |
| Cardiolipin
IgG/IgM anti- Elisa |
EIA3587 |
IgG:0-120 GPL-U/ml IgM 0-80
MPL/U/ml |
10 ul serum or plasma |
Quant |
96 wells |
| Cardiolipin
IgM (ref. sera optional, price on req.) |
EIA2789 |
|
serum, 10uL |
SemiQuant |
96 wells |
| Cardiolipin
Screen IgG/IgM anti- Elisa |
EIA3589 |
|
|
Quant |
96 wells |
| CART
(Cocaine and Amphetamine RNA Transcript) Elisa |
EIA4427 |
0-100 ng/ml //
- |
50 ul plasma |
Quant |
96 w ells |
| Casein
IgA Elisa |
EIA4297 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| Casein
IgG Elisa |
EIA4298 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| Caspase-8
(human) Elisa |
EIA4863 |
0.16 - 10 ng/mL ///
0.10 ng/mL |
50 ul cell lysate, cell culture
supernatants, s |
Quant |
96 wells |
| Caspase-9
(human) Elisa |
EIA4860 |
1.6 - 100 ng/mL ///
0.4 ng/mL |
50 ul cell lysate, cell culture
supernatants, s |
Quant |
96 wells |
| Cat
Combi Research Elisa (Adren./Noradren.) |
EIA4892 |
0.45 - 45 ng/ml ///
0.3/02 ng/ml |
1-750 uL; for various sample
types |
Quant |
2x96 wells |
| Catcombi
Elisa (Adrenaline/Noradrenaline) |
EIA3175 |
Adren:1. -150 ul/ml, Noradren:
5-500 |
10 ul extracted plasma or urine |
Quant |
2 x 96 wells |
| Catenin,
human Total beta-Catenin |
EIA4356 |
125 - 8000 pg/ml //
26.8 pg/ml |
100 ul diluted cell Lysate |
Quant |
96 wells |
| Cathepsin
G, anti- Elisa |
EIA3600 |
|
|
Quant |
96 wells |
| CAV
(Canine Adeno Virus) antibodies |
EIA2480 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| CCV
(Canine Corona Virus) IgG antibodies |
EIA2482 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| CCV
(Canine Corona Virus) IgM antibodies |
EIA2483 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| CD23
(soluble) Elisa |
EIA3874 |
1 - 20 U/mL 0.15U/mL |
50 ul serum |
Quant |
96 wells |
| CDV
(Canine Distemper Virus) IgG antibodies |
EIA2478 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
96 wells |
| CDV
(Canine Distemper Virus) IgM antibodies |
EIA2479 |
Negative and Positive Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| CEA |
EIA1868 |
0 - 100 ng/ml // 0.44 ng/ml |
50 ul serum / plasma |
Quant |
96 wells |
| CEA |
EIA1871 |
1.0 ng/ml |
serum |
Quant |
96 wells |
| Centromer
B, anti- Elisa |
EIA3569 |
|
|
Quant |
96 wells |
| CETP
Activity (Cholesteryl ester transfer
protein) |
EIA4414 |
zero standards |
1-3 ul serum / plasma |
Qual |
100 tests |
| CH 50 |
EIA3989 |
controls qualitative |
50 ul serum |
Qual |
96 wells |
| Chemerin
human Elisa |
EIA5065 |
0.5 - 16 ng/mL ///
0.13 ng/mL |
100 uL serum and plasma |
Quant |
96 wells |
| Chikungunya
IgG |
EIA5102 |
neg., pos., cut-off control
/// >90% |
10 uL serum or plasma |
Qual |
96 wells |
| Chikungunya
IgM Elisa |
EIA5103 |
neg., pos., cut-off control ///
>90% |
10 uL serum or plasma |
Qual |
96 wells |
| Chlamydia IgM (pneumoniae) |
EIA2941 |
|
|
Qual |
96 wells |
| Chlamydia
(psittaci/trachomatis) Ab (cats only) |
EIA2474 |
Positive and Negative Control |
100 ul Serum (1:50 diluted) |
|
96 wells |
| Chlamydia
IgA (pneumoniae) |
EIA2942 |
|
|
Qual |
96 wells |
| Chlamydia
IgA (trachomatis) |
EIA3461 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Chlamydia
IgG (pneumoniae) |
EIA2940 |
|
|
Qual |
96 wells |
| Chlamydia
IgG (pneumoniae) |
EIA3912 |
pos. + neg. control |
10 ul serum or plasma |
Qual |
96 wells |
| Chlamydia
IgG (trachomatis) |
EIA3462 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Chlamydia
IgM (pneumoniae) |
EIA3913 |
pos. + neg. control |
10 ul serum or plasma |
Qual |
96 wells |
| Chlamydia
IgM (trachomatis) |
EIA3463 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Cholecystokinin
(CCK) (26-33) Elisa |
EIA4393 |
0 - 100 ng / ml /// - |
50 ul plasma |
Quant |
96 wells |
| Chromogranin
A Elisa |
EIA4521 |
31 - 830 ng/ml //
5 ng/ml |
25 ul serum |
Quant |
96 wells |
| CHV
(Canine Herpes Virus) antibodies |
EIA2481 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| CK-MB |
EIA4112 |
|
|
Quant |
96 wells |
| Clostridium
piliforme (mouse) EcoElisa |
EIA4952 |
pos. + neg. control ///
- |
50 uL 1:60 dil .serum |
Qual |
48 wells |
| Clostridium
piliforme (mouse) EcoElisa |
EIA4953 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Clostridium
piliforme (rat) EcoElisa |
EIA4954 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Clostridium
piliforme (rat) EcoElisa |
EIA4955 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| CMV IgG |
EIA1797 |
|
serum |
Quant |
96 wells |
| CMV IgG
(Cytomegalovirus) |
EIA3468 |
pos. / neg control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| CMV IgM |
EIA1796 |
|
serum |
Quant |
96 wells |
| CMV IgM
(Cytomegalovirus) |
EIA3469 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Complement
C3a des Arg, (human) Correlate EIA |
EIA3631 |
|
|
Quant |
5 x 96 wells |
| Complement
C3a des Arg, (human) Correlate EIA |
EIA3641 |
|
|
Quant |
96 wells |
| Complement
C4a des Arg, Correlate EIA |
EIA3632 |
|
|
Quant |
5 x 96 wells |
| Complement
C4a des Arg, Correlate EIA |
EIA3642 |
|
|
Quant |
96 wells |
| Corona/
Sialodacryoadenitis Virus (rat) EcoElisa |
EIA4974 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Corona/
Sialodacryoadenitis Virus (rat) EcoElisa |
EIA4975 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Corticosterone
Elisa |
EIA4164 |
0 - 240 nmol/l // Sensitivity to determine |
20 ul serum / plasma |
Quant |
96 wells |
| Corticotropin
Releasing Factor (CRF) mouse, rat, human |
EIA5082 |
1-10000 pg/ml ///
/ |
50 ul prepared blood sample |
Quant |
96 wells |
| Corticotropin
Releasing Factor (human - rat - mouse) |
EIA1631 |
0.2-2.0 ng/ml |
plasma |
Quant |
96 wells |
| Cortisol |
CLA4651 |
0.5 - 60 ug/dL ///
0.15 ug/dl |
20 ul serum |
Quant |
96 wells |
| Cortisol
(human) |
EIA1887 |
2,5 ng/ml |
serum / plasma |
Quant |
96 wells |
| Cortisol
(human) salivary |
SLV2930 |
2000 - 80000 pg/ml //
1140 pg/ml |
100 ul saliva |
Quant |
96 wells |
| Cortisol
(serum) CLA |
CLA4666 |
20-800 ng/ml ///
0.48 ng/ml |
20 ul serum |
Quant |
96 wells |
| Cortisol
(urinary) EIA |
EIA2989 |
|
|
Quant |
96 wells |
| Cortisol
HS salivary |
SLV4635 |
0.1 - 30 ng/ml ///
0.03 ng/ml |
100 ul saliva |
Quant |
96 wells |
| Cortistatin-14
(rat) |
EIA3802 |
|
|
Quant |
96 wells |
| Cotinine
(saliva) EIA |
EIA3243 |
5 - 50 ng/ml Cotinine (3
calibrators) |
Saliva samples |
SemiQuant |
96 wells |
| Cotinine
(serum) EIA |
EIA3242 |
10 - 50 ng/ml |
serum or plasma samples |
SemiQuant |
96 wells |
| Cotinine
(urine) EIA |
EIA1377 |
neg/pos control |
urine |
Qual |
96 wells |
| COX
Activity Kit (Cyclooxygenase) |
CLA4738 |
|
|
|
96 wells |
| C-Peptide |
EIA1293 |
0.2-16 ng/ml |
serum, plasma, urine |
Quant |
96 wells |
| C-Peptide
(human) |
EIA4262 |
95 - 3720 pmol/l // 15 pmol/l |
25 ul serum, plasma or urine |
Quant |
96 wells |
| CPV
(canine parvo virus) antigen Faeces |
EIA2477 |
Positive and Negative Control |
100 ul Serum (1:2 diluted) |
|
96 wells |
| CPV IgG
(canine parvo virus) antibodies Faeces |
EIA2475 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
96 wells |
| CPV IgM
(canine parvo virus) antibodies |
EIA2476 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
96 wells |
| CRP
(canine) Elisa |
EIA4694 |
1.5 - 40 ug/mL ///
3.6 ng/ml |
2 ul serum |
Quant |
96 welss |
| CRP
(mouse) Elisa |
EIA4823 |
1.56 - 25 ng/ml /// 2.5 ng/ml |
10 ul serum / plasma / fluids |
Quant |
96 wells |
| CRP
(rat) Elisa |
EIA4695 |
4.9 - 133.3 ul/mL ///
2.5 ug/ml |
2 ul serum |
Quant |
96 wells |
| CRP, HS
(C-Reactive Protein) |
EIA3954 |
|
|
Quant |
96 wells |
| Cryptosporidium
Ag (stool) |
EIA3467 |
pos. / neg. control //
93 % |
stool |
Qual |
96 wells |
| Cyclic
AMP |
EIA2096 |
|
|
Quant |
192 wells |
| Cyclic
AMP (direct) |
EIA3065 |
|
urine |
|
96 wells |
| Cyclic
AMP Parameter Assay Kit |
EIA3062 |
|
urine |
Quant |
96 wells |
| Cyclic
GMP |
EIA2097 |
|
|
Quant |
192 wells |
| Cyclic
GMP (direct) |
EIA3069 |
|
|
Quant |
96 wells |
| Cyclic
GMP Parameter Assay Kit |
EIA3067 |
|
|
Quant |
96 wells |
| Cyfra
21-1 |
CLA4731 |
3 - 50 ng/ml ///
0.03 ng/ml |
50 ul serum, heparin plasma |
Qual |
96 wells |
| Cyfra
21-1 Elisa |
EIA3943 |
3 - 50 ng/ml // <0.266 ng/ml |
50 ul serum/plasma |
Quant |
96 wells |
| Cystatin
C (human) Elisa |
EIA4394 |
1 - 5000 ng/ml // 0.02 ng/well |
10 ul serum and tissue culture
medium |
Quant |
96 wells |
| Cysteinyl
Leukotriene correlate EIA |
EIA3615 |
|
|
Quant |
96 wells |
| Cysteinyl
Leukotriene correlate EIA |
EIA3633 |
|
|
Quant |
5 x 96 wells |
| Cysticercosis |
EIA2905 |
|
|
Quant |
96 wells |
| Cytochrome
C Elisa |
EIA4490 |
28.13 - 900 pg/mL //
6.03 pg/mL |
100 uL cell lysate |
Quant |
96 wells |
| Cytomegalovirus
(guinea pig) EcoElisa |
EIA4958 |
pos. + neg. control ///
- |
50 uL 1:60
dil. serum |
Qual |
48 wells |
| Cytomegalovirus
(guinea pig) EcoElisa |
EIA4959 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Cytomegalovirus
(mouse) EcoElisa |
EIA4956 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Cytomegalovirus
(mouse) EcoElisa |
EIA4957 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Dengue
IgG |
EIA3470 |
pos. / neg. control |
10ul serum (1+100 diluted) |
Qual |
96 wells |
| Dengue
IgM |
EIA3471 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| DHEA
(Dehydro-epiandrosterone) Elisa |
EIA3415 |
0-30 ng/ml |
20 ul serum |
Quant |
96 wells |
| DHEA S
(Dehydro-epiandrosterone Sulphate) |
EIA1562 |
0.1-10 ug/ml |
serum, plasma |
Quant |
96 wells |
| DHEA
Salivary Elisa |
SLV3012 |
10 - 1440 pg/mL ///
3.3 pg/ml |
50 ul saliva |
Quant |
96 wells |
| DHEA-S |
CLA4652 |
0.02 - 10 ug/dL ///
0.02 ug/dl |
25 ul serum |
Quant |
96 wells |
| DHEA-S
(serum) CLA |
CLA4667 |
|
serum |
Quant |
96 wells |
| DHEA-S
Saliva |
SLV4409 |
0.2 - 12 ng/ml // 25 pg/mL |
50 uL Saliva |
Quant |
96 wells |
| Diabetes
Control Set (human Insulin) Low + High |
EIA2338 |
|
|
|
2 x 0.5 ml |
| Digoxin |
EIA3268 |
|
|
Quant |
96 wells |
| Diol, 3
alpha diol G (5aAndrostone 3a17Bdiol Glucuronide) |
CLA4649 |
0.25 - 50 ng/ml //
0.1 ng/ml |
5 ul serum |
Quant |
96 wells |
| Diphtheria
IgG Toxoid Ab (corynebacterium diphtheriae) |
EIA3466 |
4 standards (conc:?) // - |
100 ul serum (diluted 1:100) |
Quant |
96 wells |
| DNA (ds)
anti- Antibody* |
EIA2574 |
Positive, negative Control,
positive calibrator |
|
|
96 wells |
| DNA (ds)
IgA, anti- Elisa |
EIA3565 |
|
|
Quant |
96 wells |
| DNA (ds)
IgG |
EIA2774 |
|
10 uL serum |
SemiQuant |
96 wells |
| DNA (ds)
IgM, anti Elisa |
EIA3564 |
|
|
Quant |
96 wells |
| DNA (ds)
Screen, anti- Elisa |
EIA3566 |
12.5 - 200 U/ml //
1U/ml |
10 ul serum / plasma |
Quant |
96 wells |
| DNA (ss)
anti- Elisa |
EIA3567 |
|
|
|
96 wells |
| Dopamin
Research Elisa |
EIA4824 |
25 - 6,400 pg/sample ///
8.3 pg/sample |
1-100 uL tissues homogenates,
dialysates |
Quant |
96 wells |
| Dopamine
Elisa |
EIA4161 |
12-3840 ng/ml //7.5ng/mlurin,12.5pg/mlplas |
600 ul plasma o. 10 ul urine |
Quant |
96 wells |
| Dopamine
Elisa |
EIA4615 |
12-2250 ng/mL // urin 5 ng/mL;
plas 4 pg/ml |
500 uL plasma, 20 uL urine |
Quant |
96 wells |
| DR4
(human) Elisa |
EIA3998 |
39 - 2500 pg/ml / <14 pg/ml |
100 ul cell extract |
Quant |
96 wells |
| DR5
(human) Elisa |
EIA4008 |
70 - 500 pg/ml = quant. /
<15 pg/ml |
100 ul cell extract |
Quant |
96 wells |
| E. Coli
Verotoxin 1+2 Ag (stool) Elisa |
EIA4452 |
pos./neg. control // 84.6 % |
stool speciment |
Qual |
96 wells |
| Echinococcus
granulosus IgG |
EIA3472 |
pos./ neg. / cut off control
/ 97.8 % |
100 ul serum (diluted 1:64) |
Qual |
96 wells |
| Ectromelia
Virus (mouse) EcoElisa |
EIA4960 |
pos. + neg. control ///
- |
50 uL 1:60 dil serum |
Qual |
48 wells |
| Ectromelia
Virus (mouse) EcoElisa |
EIA4961 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| EGF
(human) (Epidermal Growth Factor) |
EIA1734 |
0.5 ng/ml |
Urine |
Quant |
96 wells |
| ENA
Combi |
EIA3572 |
|
|
Quant |
96 wells |
| ENA
Screen (entractable nuclear antigen) |
EIA2779 |
|
serum, 10 uL |
SemiQuant |
96 wells |
| ENA-4-Profile
Elisa |
EIA3977 |
qualitative, cut-off OD Quotient |
10 ul serum or plasma |
Qual |
4x24 tests |
| ENA-6-Profile |
EIA2780 |
|
serum, 50 uL |
SemiQuant |
96 wells |
| ENA-6-Profile |
EIA3901 |
Qualt., Cut-off OD-Quotient |
10 ul Serum or Plasma |
Qual |
6x16 tests |
| ENA-6-Screen |
EIA3571 |
|
|
Quant |
96 wells |
| Encephalitozoon
cuniculi (guinea pig) EcoElisa |
EIA4966 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Encephalitozoon
cuniculi (guinea pig) EcoElisa |
EIA4967 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Encephalitozoon
cuniculi (hamster EcoElisa |
EIA4969 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Encephalitozoon
cuniculi (hamster) EcoElisa |
EIA4968 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Encephalitozoon
cuniculi (mouse) EcoElisa |
EIA4962 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Encephalitozoon
cuniculi (mouse) EcoElisa |
EIA4963 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Encephalitozoon
cuniculi (rat) EcoElisa |
EIA4964 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Encephalitozoon
cuniculi (rat) EcoElisa |
EIA4965 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Endothelin
1 |
EIA3111 |
|
|
Quant |
96 wells |
| Endothelin
1 (Big) (rat) TiterZyme EIA |
EIA3617 |
|
|
Quant |
96 wells |
| Endothelin
1 (Big) , human |
EIA3110 |
|
|
Quant |
96 wells |
| Endothelin
2 (ET-2) (human - canine) |
EIA3421 |
|
|
Quant |
96 wells |
| Endothelin-1
(H - R - M - B - P - C - R) |
EIA3420 |
|
|
Quant |
96 wells |
| Entamoeba
histolytica IgG (Amebiasis) Elisa |
EIA3474 |
pos. / neg. control // 92 % |
100 ul serum (diluted 1:64) |
Qual |
96 wells |
| Enterovirus
IgG Elisa |
EIA4901 |
... ///
91.6 % pos+neg control |
10 ul serum, plasma |
Qual |
96 wells |
| Enterovirus
IgM Elisa |
EIA4902 |
... ///
91.6 % |
10 ul serum, plasma |
Qual |
96 wells |
| Epstein
Barr Virus (EBV-EBNA) IgG |
EIA4246 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Epstein
Barr Virus (EBV-EBNA) IgM |
EIA4247 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Epstein
Barr Virus (EBV-VCA) IgG |
EIA3475 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Epstein
Barr Virus (EBV-VCA) IgM |
EIA3476 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Epstein
Barr Virus EA IgG |
EIA2796 |
|
serum, 10uL |
Qual |
96 wells |
| Epstein
Barr Virus EBNA IgA*, Elisa |
EIA2519 |
|
|
|
96 wells |
| Epstein
Barr Virus EBNA-1 IgG |
EIA2795 |
|
serum, 10uL |
Qual |
96 wells |
| Epstein
Barr Virus VCA IgG |
EIA2793 |
|
serum, 10uL |
Qual |
96 wells |
| Epstein
Barr Virus VCA IgM |
EIA2794 |
|
serum, 10uL |
Qual |
96 wells |
| Erythropoietin
(Epo) - single-step sandwich- |
EIA3646 |
6mU/mL |
human serum |
Quant |
96 wells |
| Estradiol |
EIA2693 |
0 / 4.6pg/ml |
serum, plasma |
Quant |
96 wells |
| Estradiol
(serum) CLA |
CLA4664 |
|
serum |
Quant |
96 wells |
| Estradiol
Saliva (E2) |
SLV4188 |
0.1 - 100 pg/ml // 0.085 pg/ml |
100ul saliva |
Quant |
96 wells |
| Estradiol
US (ultra sensitive) |
EIA4399 |
3 - 200 pg/ml // < 1pg/ml |
100 ul serum, plasma |
Quant |
96 wells |
| Estradiol,
17-beta |
EIA3125 |
|
|
Quant |
96 wells |
| Estriol
(E3), Free |
EIA1612 |
1-40 ng/ml |
serum |
Quant |
96 wells |
| Estriol
Saliva |
CLA4653 |
0.1 - 100 pg/ml ///
0.7 pg/ml |
50 ul saliva |
Quant |
96 wells |
| Estriol,
Free (saliva) |
SLV3653 |
0.1 - 12 ng/ml //
2 pg/ml |
20 ul Saliva |
Quant |
96 wells |
| Estriol,
total |
EIA3717 |
2,0 - 200,0 ng/ml / 40
pg |
20 ul |
Quant |
96 wells |
| Estrone |
EIA4079 |
|
|
|
96 wells |
| Estrone
Elisa |
EIA4174 |
15 - 2000 pg/ml // 6,3 pg/ml in research |
50 ul Serumin research |
Quant |
96 wells |
| Estrone
Saliva |
CLA4655 |
2 - 800 pg/ml //
1.0 pg/ml |
100 ul saliva |
Quant |
96 wells |
| Estrone
Serum |
CLA4654 |
15 - 2000 pg/ml ///
8.8 pg/ml |
50 ul serum |
Quant |
96 wells |
| FABP,
human (Fatty Acid Binding Protein) |
EIA4412 |
1 - 100 ng/ml //
- |
100 ul serum |
Quant |
96 wells |
| Fasciola
Hepatica (bovine) Elisa |
EIA4324 |
pos., sample : qualitative test |
10 ul bovine serum |
Qual |
96 wells |
| Fasciola
hepatica (bovine, sheep) Elisa |
EIA5075 |
pos. control ///
n.d. |
10 uL serum, 25 uL milk |
|
96 wells |
| Fasciola
Hepatica IgG (human) Elisa |
EIA4503 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| FCoV Ab
(indication for FIP disease) |
EIA2468 |
Positive and Negative Control |
100 ul Serum ( 3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| FCV
(Feline Calici Virus) antibodies |
EIA2473 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1-810) |
|
96 wells |
| FeLV-p27
(Feline Leukemia Virus) antigen |
EIA2469 |
Positive and Negative Control |
50 ul Serum (dilution 1:1) |
|
96 wells |
| Ferritin |
EIA1872 |
5.0 ng/ml |
serum |
Quant |
96 wells |
| Ferritin
Elisa |
EIA4292 |
15 - 1500 ng/ml //
5ng/ml |
25 ul serum, plasma |
Quant |
96 wells |
| Ferritin
Elisa |
EIA4408 |
5 - 100 ng/ml //
1.0 ng/ml |
20 uL serum / plasma |
Quant |
96 wells |
| Fetuin A
Elisa |
EIA4522 |
12.5 - 370 ng/ml //
5 ng/ml |
25 ul diluted serum, Tissues
extracts |
Quant |
96 wells |
| FGF-23
(Fibrolast growth factor 23) (human intact) |
EIA4737 |
6-650 pg/mL ///
1.0 pg/mL |
150 uL plasma or cell culture
media |
Quant |
96 wells |
| FHV
(Feline Herpes Virus) antibodies |
EIA2472 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| Fibronectin,
(human) |
EIA1736 |
|
Biological sample |
Quant |
96 wells |
| FIV
p24/p17 (Feline Immunodeficiency Virus) Ab |
EIA2463 |
Positive and Negative Control |
100 ul serum (1:100 diluted) |
|
96 wells |
| Fodrin,
anti-alpha-Fodrin |
EIA3978 |
|
|
|
96 wells |
| Food
Additives Allergy Screening Elisa |
EIA4725 |
50 - 400 U/ml ///
- |
25 uL serum |
Quant |
288 wells |
| Food
Allergies IgG - Allerquant 90G |
EIA1745 |
on request |
serum |
Quant |
288 tests |
| FPV
(Feline Panleucopenia Virus) Ab EIA |
EIA2467 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:50 - 1:1350) |
|
96 wells |
| FPV
(Feline Panleukopenia Virus) ag EIA |
EIA2466 |
Positive and Negative Control |
100 ul Faeces (1:2 diluted) |
Qual |
96 wells |
| FSH
(Follicle Stimulating Hormone) |
EIA1288 |
5-100 mIU/ml |
serum |
Quant |
96 wells |
| FSH
(Follicle Stimulating Hormone) |
EIA1785 |
2.5 mIU/ml |
serum |
Quant |
96 wells |
| GAD-65,
anti EIA |
EIA1910 |
- /// 85 % |
serum |
Qual |
96 wells |
| Galactose
(with Membrane Plate) |
EIA1488 |
<1.5 mg/dL |
blood |
Quant |
960 wells |
| Galactose
(without Membrane Plate) |
EIA1489 |
<1.5 mg/dL |
blood |
Quant |
960 wells |
| Galactose
neonatal (with Membrane Plate) |
EIA1486 |
< 1.5 mg/dL |
blood |
Quant |
192 wells |
| Galactose
neonatal (without Membrane Plate) |
EIA1487 |
<1.5 mg/dL |
blood |
Quant |
192 wells |
| Galectin-3
(human) Elisa |
EIA4858 |
0.39 - 25.0 ng/mL ///
0.12 ng/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Gardenella
Vaginalis IgA Elisa |
EIA4516 |
-
/ / |
10 ul serum / vaginal liquid |
Qual |
96 wells |
| Gardenella
Vaginalis IgG Elisa |
EIA4515 |
-
/ - |
10 ul serum / vaginal liquid |
Quant |
96 wells |
| Gardnerella
Vaginalis IgM Elisa |
EIA4514 |
-
/ - |
10 ul serum / vaginal liquid |
Qual |
96 wells |
| Gastrin
(human) |
EIA4187 |
39.1 - 10000 pg/mL / 7.27 pg/mL |
100 uL serum |
Quant |
96 wells |
| Gastrin
1 (human) EIA |
EIA3266 |
|
|
Quant |
96 wells |
| Gastrin
1 (rat) (1-17) Elisa |
EIA4501 |
78.1 - 5000 pg/mL //
78.1 pg/mL |
50 uL tissue culture
media,plasma, serum |
Quant |
96 wells |
| Gastrin
Inhibitor Peptide (human) (GIP) |
EIA4142 |
0.41-3.12 ng/ml //
0.41 ng/ml |
50 ul plasma, serum, culture
media |
Quant |
96 wells |
| Gastrin
Inhibitor Peptide (human) (GIP) Elisa |
EIA4527 |
8.2 - 2000 pg/ml //
8.2 pg/ml |
20 ul serum, plasma, tissue
extract |
Quant |
96 wells |
| Gastrin
Inhibitor Peptide (rat/mouse) (GIP) Elisa |
EIA4528 |
8.2 - 2000 pg/ml //
8.2 pg/ml |
10 ul serum, plasma, tissue
extract |
Quant |
96 wells |
| GBM,
anti- Elisa |
EIA3603 |
|
|
Quant |
96 wells |
| G-CSF
(Granulocyte-Colony Stimulating Factor) |
EIA3876 |
39 - 2500 pg/mL <20 pg/mL |
50 ul |
Quant |
96 wells |
| Ghrelin
(active) human Elisa |
EIA4710 |
25 - 2000 pg/mL ///
8 pg/mL |
20 ul serum or plasma |
Quant |
96 wells |
| Ghrelin
(acylated) human Elisa |
EIA4686 |
1.96 - 250 pg/ml /// 4 pg/ml |
100 uL (1:5 diluted) EDTA plasma |
Quant |
96 wells |
| Ghrelin
(human) |
EIA3706 |
|
|
Quant |
96 wells |
| Ghrelin
(rat - mouse) |
EIA3707 |
|
|
Quant |
96 wells |
| Ghrelin
(total) human Elisa |
EIA4709 |
100 - 5000 pg/mL ///
30 pg/mL |
20 uL serum or plasma |
Quant |
96 wells |
| Gliadin
IgA |
EIA3370 |
|
|
Qual |
96 wells |
| Gliadin
IgA (anti- ) Elisa |
EIA5081 |
4 - 160 U/mL ///
90.9 % |
100 ul serum, plasma |
Quant |
96 wells |
| Gliadin
IgG |
EIA3371 |
|
|
Qual |
96 wells |
| Gliadin
IgG (anti- ) Elisa |
EIA5080 |
4.7 - 100 U/mL ///
86.4 % |
100 ul serum, plasma |
Quant |
96 wells |
| Gliadin
IgG, anti- Elisa |
EIA3605 |
|
|
Quant |
96 wells |
| Gliadin
Screen, (Anti-Gliadin) Elisa |
EIA4465 |
6.3 - 100 U/ml //
1 U/ml |
10 ul serum / plasma |
Quant |
96 wells |
| Glucagon
Like Peptide 1 (active) |
EIA3056 |
|
|
Quant |
96 wells |
| Glucagon
Like Peptide 1 (GLP-1) (7-26) Amide |
EIA4141 |
|
|
Quant |
96 wells |
| Glucagon
like peptide-1 (GLP-1) total Elisa |
EIA5095 |
2.1 - 54 pmol/L ///
1 pmol/L |
100 ul Plasma |
Quant |
96 wells |
| Glucagon
like peptide-1 (GLP-s) active (7-36) |
EIA5096 |
1.82 - 54.58 pmol/L ///
0.3 pmol/L |
100 ul Plasma |
Quant |
96 wells |
| Glycodelin
(PP14) Elisa |
EIA3779 |
|
|
Quant |
96 wells |
| Glycoprotein
1 IgG/IgM, anti-beta2 Elisa |
EIA3590 |
|
|
Quant |
96 wells |
| Glykoprotein
1 IgA, anti beta 2 - |
EIA3884 |
0 - 100 U/ml, 0.5U/ml |
10 ul serum or plasma |
Quant |
96 wells |
| Glykoprotein
1 Screen, anti beta 2 |
EIA3911 |
Neg., cut-off, Pos., Strong Pos
Ctrl. / 0.5 U/ml |
10 ul serum or plasma |
Qual |
96 wells |
| GM-CSF (Granulocyte Macrophage-Colony Stimulating Factor) |
EIA3877 |
3.9 - 250 pg/mL < 1.25 pg/mL |
50 ul |
Quant |
96 wells |
| GM-CSF
(human) Elisa |
EIA4859 |
8 - 500 pg/mL ///
2.9 pg/mL |
50 ul cell culture, serum plasma,
amniotic |
Quant |
96 wells |
| GM-CSF
(mouse) (Granulocyte Macrophage Stimulating Factor) |
EIA3416 |
7.8-500 pg/ml |
50 ul serum, tissue culture
supernatant |
Quant |
192 wells |
| GM-CSF
(mouse) (Granulocyte Macrophage Stimulating Factor) |
EIA3417 |
7.8-500 pg/ml |
50 ul serum, tissue culture
supernatant |
Quant |
96 wells |
| GRO/CINC
1, (rat) TiterZyme EIA |
EIA3618 |
|
|
Quant |
96 wells |
| Growth
Hormone (Rat/Mouse) Elisa |
EIA4614 |
0.21 - 50 ng/ml //
0.07 ng/ml |
10 ul rat or mouse serum, plasma |
Quant |
96 wells |
| Growth
Hormone Releasing Factor (human) EIA |
EIA3429 |
|
|
Quant |
96 wells |
| H.
Pylori IgA |
EIA3483 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| H.
Pylori IgA, anti- (qualitative) |
EIA4099 |
|
|
Qual |
96 wells |
| H.
Pylori IgG |
EIA3484 |
pos / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| H.
Pylori IgG (Gastritus & Peptic Ulcer) qualitative |
EIA1791 |
98% |
serum |
Qual |
96 wells |
| H.
Pylori IgG (Gastritus & peptic Ulcer) quantitative |
EIA3057 |
|
|
Quant |
96 wells |
| H.
Pylori IgG, anti- (Gastritus & Peptic Ulcer) qualitative |
EIA4100 |
|
|
Qual |
96 wells |
| H.
Pylori IgM (qualitative) |
EIA2111 |
|
|
Qual |
96 wells |
| H.
Pylori IgM, anti- (qualitative) |
EIA4101 |
|
|
Qual |
96 wells |
| HAMA
Elisa (human anti-mouse Ab) Magiwel |
EIA4195 |
25 - 1000 ng/ml / - |
25 ul diluted serum samples
(1:101) |
Quant |
96 wells |
| HAMA IgG
Elisa |
EIA1898 |
|
|
Quant |
96 wells |
| Hantaan
Virus (rat) EcoElisa |
EIA4970 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Hantaan
Virus (rat) EcoElisa |
EIA4971 |
pos. neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| HAV
Ab (min. order 10 kits) |
EIA4233 |
nev. / pos. control //
100 %] |
100 ul serum, plasma (human) |
Qual |
96 wells |
| HAV IgM,
anti- (IgM Antibody to Hepatitis A Virus) (ELISA) |
EIA3889 |
|
|
Qual |
96 wells |
| HBc Ab
(Screening) Elisa |
EIA4872 |
- ///
94.9 % |
50 uL serum, plasma |
Qual |
96 wells |
| HBc Ab
screening Elisa (min order 10kits) |
EIA4086 |
neg., pos., control, qualitative |
50 ul serum, plasma |
Qual |
96 wells |
| HBc IgM
Elisa (min. order 10kits) |
EIA4085 |
0-100 PEI U/ml /
100 % |
10 ul serum, plasma |
Quant |
96 wells |
| HBc IgM,
anti-(IgM Antibody to Hep B Core Antigen) |
EIA3895 |
|
|
Qual |
96 wells |
| HBc,
anti-( IgG/IgM Antibodies to Hep B Core Antigen) |
EIA3894 |
|
|
Qual |
96 wells |
| HBe,
anti- (Antibody to Hep B e Antigen)
(ELISA) |
EIA3891 |
|
|
Qual |
96 wells |
| HBeAg (Hepatitis B e Antigen) (ELISA) |
EIA3890 |
|
|
Qual |
96 wells |
| HbeAg/Ab
Elisa (min. order 10 kits) |
EIA4162 |
neg., pos. control,
qualitative / 0.5 PEI U/ml |
50 ul serum |
Qual |
96 wells |
| HBs Ab
Elisa (min. order 10 kits) |
EIA4135 |
0-500 WHO mlU/ml // 5 WHO mlU/ml |
100 ul serum, plasma |
Quant |
96 wells |
| HBs Ag
one Step Elisa |
EIA5051 |
neg., pos., cut-off control |
150 uL serum, or plasm |
Qual |
192 wells |
| HBs,
anti- Antibody to Hepatitis B Surface
Antigen) (ELISA) |
EIA3893 |
|
|
Qual |
96 wells |
| HBsAg ( Hepatitis B Surface Antigen) (ELISA) |
EIA3892 |
|
|
Qual |
96 wells |
| HCG
(total), beta (human serum) |
EIA1911 |
5-200 mlU/ml |
25 ul serum |
Quant |
96 wells |
| HCG
(intact), human serum only |
EIA1469 |
std. range 5 - 1000 mIU/ml |
serum |
Quant |
96 wells |
| HCG
(visual) Elisa |
EIA2113 |
|
|
Qual |
96 wells |
| hCG beta
(beta-human Chorionic Gonadotropin) |
EIA4115 |
|
|
Quant |
96 wells |
| hCG
beta, free Elisa |
EIA4718 |
2.5-50 ng/ml ///
0.196 ng/ml |
50 ul serum |
Quant |
96 wells |
| HCG
Intact Elisa (serum) |
EIA1783 |
2.0 mIU/ml |
serum |
Quant |
96 wells |
| HCV
AB (min order 10 kits) |
EIA3903 |
neg. / pos. control, qualt. |
10 ul serum, plasma (human) |
Qual |
192 wells |
| HCV Ab
screening3rd generation |
EIA5063 |
- ///
100 % |
10 uL serum, plasma |
Qual |
480 wells |
| HCV
anti- (Antibody to Hepatitis C Virus)
(ELISA) |
EIA3896 |
|
|
Qual |
96 wells |
| HCV IgG
(4th generation Synthetic Ag) |
EIA3482 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| HDV Ab
Elisa (min. order 10 kits) |
EIA4269 |
negative + positive control |
50 ul serum, plasma |
Qual |
96 wells |
| HDV Ag
Elisa (min. order 10 kits) |
EIA4268 |
negative + positiv control |
100 ul serum, plasma |
Qual |
96 wells |
| Heartworm
Ag Canine Elisa |
EIA4795 |
neg. / pos. control |
seum and plasma |
Qual |
96 wells |
| Hepatitis
Virus (mouse) EcoElisa |
EIA4972 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Hepatitis
Virus (mouse) EcoElisa |
EIA4973 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Hepatocyte
Growth Factor (human) (HGF) |
EIA3791 |
156-10,000 pg/ml < 19 og.nk |
50 ul |
Quant |
96 wells |
| Hepcidin
25 c-terminal Elisa |
EIA4705 |
3.85 - 140.0 ng/mL ///
0.9 ng/mL |
20 ul serum |
Quant |
96 wells |
| Hepcidin
Prohormone (EIA4015) Elisa |
EIA4644 |
10 - 1000 ng/ml /// 3.95 ng/ml |
50 ul serum |
Quant |
96 wells |
| HETE-12
(12(S)-HETE TiterZyme) |
EIA1584 |
0.25-50 ng/ml |
EDTA-plasma |
Quant |
96 wells |
| HETE-15 |
EIA1411 |
1.24 pg/ml |
plasma |
Quant |
96 wells |
| HETE-15
(S), Correlate EIA |
EIA3630 |
|
|
Quant |
5 x 96 wells |
| HEV Ab
Elisa (min. order 10 kits) |
EIA4057 |
neg., pos control qualitative
, >98% |
10 ul serum, plasma (human) |
Qual |
96 wells |
| HEV Ab
Elisa (min. order 10 kits) |
EIA4416 |
pos. / neg. control // - |
10 uL serum, plasma |
Qual |
96 wells |
| HEV IgG
(Hepatitis E Virus IgG) (min. order 2 kits) |
EIA1813 |
cutoff value |
serum or plasma |
Qual |
96 wells |
| HGH
(Human Growth Hormone) |
EIA1787 |
0.5 ng/ml |
serum |
Quant |
96 wells |
| HIAA
(5-Hydroxy-3-Indole Acetic Acid) |
EIA1886 |
0.2 mg/L |
urine |
Quant |
96 wells |
| HIAA ,
5-HIAA (urine) |
EIA4482 |
0.5 - 50 mg/l //
0.17 mg/l |
50 ul urine |
Quant |
96 wells |
| Histamine
Cell Culture Research Elisa |
EIA4616 |
0.5 - 50 ng/ml //
0.2 ng/ml |
10 ul cell cultue |
Quant |
96 wells |
| Histamine
Elisa - |
EIA4005 |
|
serum, plasma, urine, cell
culture |
Qual |
96 wells |
| Histamine
Food Elisa |
EIA4428 |
0,5 - 50 ug/l //
0.15 ug/l |
100 uL of extracts of fish meal,
fresh fish |
Quant |
96 wells |
| Histamine
Intolerance (DAO active) Elisa |
EIA4599 |
6 to 60 U / ml //
2.5 U/ml. |
250 ul plasma or serum |
Quant |
96 wells |
| Histamine
Research Elisa |
EIA4890 |
0.3 - 30 ng/ml ///
0.2 ng/mL |
10ul EDTA plasma from diff.
animal species |
Quant |
96 wells |
| Histone,
anti- Elisa |
EIA3568 |
|
|
Quant |
96 wells |
| HIV
1&2&0&P24 Elisa |
EIA4847 |
--- ///
up to 100 % pos./neg. control |
150 uL serum, plasma |
Qual |
192 wells |
| HIV 1+2
Elisa * (min order 3 kits) |
EIA1423 |
|
serum or plasma |
Quant |
96 wells |
| HIV 1+2
IgG/M |
EIA3491 |
pos. / neg. control |
20 ul serum |
Qual |
96 wells |
| HIV 1+2,
anti- (Sandwich) (Ab to HIV 1&2) (ELISA) |
EIA3897 |
|
|
Qual |
96 wells |
| HIV
1+2+0 Ab (min order 10kits) |
EIA3904 |
pos./neg. control, qualit. / >99 % |
10 ul serum, plasma (human) |
Qual |
192 wells |
| HO-1
(human) BASIC ELISA |
EIA5064 |
0.195-12.5 ng/mL ///
0.049 ng/mL |
100 ul cell lysates and
microsomes |
Quant |
5 x 96 wells |
| Homocysteine |
EIA2925 |
|
|
Quant |
96 wells |
| Homocysteine
Controls |
EIA3329 |
|
|
|
3x1 vial |
| hPL
(Placental Lactogen, Human) |
EIA1283 |
1.25-20 mg/ml |
serum |
Quant |
96 wells |
| HPV IgG,
Elisa |
EIA4907 |
- ///
- |
10 uL serum, plasma |
Qual |
96 wells |
| HsP 70
(anti human Hsp 70) (heat shock protein) Elisa |
EIA4470 |
31.25 - 10,000 ng/mL //
6.79 ng/mL |
100 uL serum |
Quant |
96 wells |
| Hsp70
cell lysate / tissue extracts |
EIA5056 |
0.78 ng/mL - 50 ng/mL ///
0.2 ng/mL |
100 uL prepared samples |
Quant |
96 wells |
| HSV 1
IgA*, Elisa |
EIA2532 |
|
|
|
96 wells |
| HSV 1
IgG |
EIA1802 |
|
serum |
Quant |
96 wells |
| HSV 1
IgG (Herpes Simplex Virus) |
EIA3485 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| HSV 1
IgG (Herpes Simplex Virus) ref.sera opt |
EIA2799 |
|
serum: 10uL |
Qual |
96 wells |
| HSV 1
IgM |
EIA1803 |
|
serum |
Quant |
96 wells |
| HSV 1
IgM (Herpes Simplex Virus) |
EIA3486 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| HSV 1
IgM (Herpes Simplex Virus) ref. sera opt |
EIA2800 |
|
serum: 10uL |
Qual |
96 wells |
| HSV 1+2
IgG (Herpes Simplex Virus) |
EIA3489 |
pos. / neg. control |
10 ul serum (1+1)) diluted) |
Qual |
96 wells |
| HSV 1+2
IgM (Herpes Simplex Virus) |
EIA3490 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| HSV 1+2
IgM (Herpes Simplex Virus) ref. sera opt |
EIA2803 |
|
serum: 10uL |
Qual |
96 wells |
| HSV 2
IgG |
EIA1795 |
|
serum |
Quant |
96 wells |
| HSV 2
IgG (Herpes Simplex Virus) |
EIA3487 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| HSV 2
IgG (Herpes Simplex Virus) ref. sera opt |
EIA2801 |
|
serum 10uL |
Qual |
96 wells |
| HSV 2
IgM |
EIA1794 |
|
serum |
Quant |
96 wells |
| HSV 2
IgM (Herpes Simplex Virus) |
EIA3488 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| HSV 2
IgM (Herpes Stimplex Virus) ref. sera opt |
EIA2802 |
|
serum, 10uL |
Qual |
96 wells |
| HTLV
1+2 (min order 2 kits) |
EIA1811 |
|
serum or plasma |
Qual |
96 wells |
| HTLV 1+2
Ab (min 10 kits) |
EIA3905 |
pos./neg. control, qualit. / >98 % |
10 ul serum, plasma (human |
Qual |
96 wells |
| HVA |
EIA1573 |
0.125-10 mg/ml |
urine |
Quant |
96 wells |
| IAA
(Insulin Autoantibody) |
EIA1593 |
-/+ controls |
serum |
Quant |
96 wells |
| IBR
Blocking AB, 3 steps high sensitivity |
EIA3160 |
|
|
|
96 wells |
| ICA
(Intra-Cell Autoantibody) |
EIA1594 |
-/+ controls |
serum |
Qual |
96 wells |
| ICAM-1
(Intracellular Adhesion Molecule-1) or CD54 |
EIA1194 |
0.3 ng/ml |
serum or plasma |
Quant |
96 wells |
| I-FABP
Elisa |
EIA4420 |
20 to 5,000 pg/ml //
20 pg/ml |
100 ul serum, plasma, urine, cell
cuture |
Quant |
192 wells |
| IgA
Salivary Elisa |
SLV4636 |
2.5 - 2500 ug/mL ///
0.5 ug/mL |
10 uL saliva |
Quant |
96 wells |
| IgA-CIC
Elisa |
EIA3988 |
controls qualitative |
200 ul serum, plasma |
Qual |
96 wells |
| IgE
(Immunoglobulin E) |
EIA1788 |
|
serum |
Quant |
96 wells |
| IGF 1
(equine) Elisa |
EIA3982 |
0 - 1440 ng/ml /
8ng/ml |
50 ul heparin plasma or serum |
Quant |
96 wells |
| IGF BP-1
(PP12) Elisa |
EIA3780 |
0 - 50 ng/ml |
50 ul |
Quant |
96 wells |
| IGF BP-3
Elisa |
EIA3300 |
360 - 6900 ng/ml //
10.5 ng/ml |
10 ul serum |
Quant |
96 wells |
| IGF-1 -
600 quantitative Elisa |
EIA4140 |
0 - 600 ng/mL / - |
50 ul serum |
Quant |
96 wells |
| IGF-BP3
Elisa |
EIA5049 |
460 - 16070 ng/ml /// 10 ng/ml |
10 uL serum |
Quant |
96 wells |
| IgG
(mouse) Elisa |
EIA5052 |
9,375 - 600 ng/ml ///
- |
serum, plasma |
Quant |
96 wells |
| IgG-CIC
Elisa |
EIA3986 |
controls qualitative |
20 ul serum, plasma |
Qual |
96 wells |
| IgM-CIC
Elisa |
EIA3987 |
controls qualitative |
200 ul serum, plasma |
Qual |
96 wells |
| Interferon
gamma (porcine) Elisa |
EIA4828 |
31-2000 pg/mL ///
3.3 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Influenza
A IgA Elisa |
EIA4242 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Influenza
A IgG Elisa |
EIA4238 |
pos. / neg control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Influenza
A IgM Elisa |
EIA4240 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Influenza
B IgA Elisa |
EIA4239 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Influenza
B IgG Elisa |
EIA4241 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Influenza
B IgM Elisa |
EIA4237 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Insulin
(Bovine) Elisa |
EIA4748 |
0.05 - 3 ug/L ///
0.025 ug/L |
25 uL serum / plasma |
Quant |
96 wells |
| Insulin
(Canine) Elisa |
EIA4749 |
0.02 - 1.5 ug/L ///
0.01 ug/L |
25 uL serum / plasma |
Quant |
96 wells |
| Insulin
(Equine) Elisa |
EIA4746 |
0.02 - 1.5 ug/L ///
0.01 ug/L |
25 uL serum / plasma |
Quant |
96 wells |
| Insulin
(Feline) Elisa |
EIA4919 |
5 - 700 ng/l ///
0.01 ug/L |
10 ul serum/ plasma |
Quant |
96 wells |
| Insulin
(human) |
EIA1825 |
1.5 ulU/ml |
serum / plasma |
Quant |
96 wells |
| Insulin
(human) |
EIA2935 |
1.5 iU/ml |
serum, plasma |
Quant |
96 wells |
| Insulin
(mouse) EIA |
EIA3439 |
|
|
|
96 wells |
| Insulin
(mouse) ultrasensitive EIA |
EIA3440 |
5ul sample:0.22-7.1 ug/l |
5 ul or 50 ul mouse serum, plasma |
|
96 wells |
| Insulin
(ovine) Elisa |
EIA4739 |
0.05 - 3 ug/L ///
0.025 ug/L |
25 uL serum / plasma |
Quant |
96 wells |
| Insulin
(Porcine) Elisa |
EIA4747 |
0.02 - 1.5 ug/L ///
0.01 ug/L |
25 uL serum / plasma |
Quant |
96 wells |
| Insulin
(rat) |
EIA2048 |
0.15-5.5 ug/L |
25 ul serum, plasma |
Quant |
96 wells |
| Insulin
(rat) ultrasensitive, ELISA |
EIA2943 |
|
|
|
96 wells |
| Insulin
(rat/mouse) |
EIA4127 |
0.2-10 ng/ml // 0.2 ng/ml 2 ng-10 ng per ml |
20 ul serum, plasma |
Quant |
96 wells |
| Insulin
anti- Elisa |
EIA3608 |
|
|
Quant |
96 wells |
| Insulin
Iso ELISA |
EIA2336 |
3-100 mU/L |
|
|
96 wells |
| Insulin
rat high range ELISA |
EIA3985 |
3 - 150 ug/l /
1.5ug/l |
10 ul serum, plasma |
Quant |
96 wells |
| Insulin
Ultra-Sensitive |
EIA2337 |
0.15 - 10 mU/L |
50 ul serum, plasma |
|
96 wells |
| Interferon
/ Anti-IFN alpha (human) Elisa |
EIA4853 |
3.2 - 200 ng/mL ///
1.38 ng/mL |
20 ul cell culture, serum,
plasma, urine |
Quant |
96 wells |
| Interferon
alpha (human) Elisa |
EIA4766 |
8-500 pg/ml ///
3.16 pg/ml |
20 ul cell culture supernatants,
serum |
Quant |
96 wells |
| Interferon
beta |
EIA2088 |
|
|
|
96 wells |
| Interferon
gamma (mouse) INF |
EIA4931 |
7.8 - 500 pg/mL ///
<1 pg/mL |
100 uL serum, plasma |
Quant |
96 wells |
| Interferon
gamma (mouse) INF |
EIA4932 |
7.8 - 500 pg/mL ///
<1 pg/mL |
100 uL serum, plasma |
Quant |
192 wells |
| Interferon
gamma (rat) - INF - |
EIA4582 |
21.8 - 1400 pg/mL
// <13 pg/mL |
100 ul serum, plasma |
Quant |
96 wells |
| Interferon
gamma (rat) - INF - |
EIA4583 |
21.8 - 1400 pg/mL //
<13 pg/mL |
100 uL serum, pl |
Quant |
192 wells |
| Interferon
gamma Elisa / CE |
EIA4434 |
1 - 30 IU/ml //
0.03 IU/ml |
50 uL serum |
Quant |
96 wells |
| Interferon
y (human) EIA |
EIA3277 |
1 - 30 IU / ml |
50 ul human serum |
Quant |
96 wells |
| Interferon
y (human) EIA |
EIA3278 |
1-30 IU/ml |
50 ul human serum |
Quant |
192 wells |
| Interferon
y (mouse) EIA |
EIA3378 |
7.8 - 500 pg/ml |
100 ul serum and tissue culture |
Quant |
192 wells |
| Interferon
y (mouse) Elisa |
EIA3299 |
7.8 - 500 pg/ml |
100 ul Serum, tissue culture |
Quant |
96 wells |
| Interferon
y (porcine) EIA |
EIA3178 |
7.8 500 pg/ml |
50 ul serum, plasma, cell culture
medium |
Quant |
96 wells |
| Interleukin
1 (alpha) (rat) EIA |
EIA3281 |
7.8 - 500 pg/ml |
50 ul rat serum |
Quant |
192 wells |
| Interleukin
1 (beta) (human) |
EIA0977 |
10.24-400 pg/mL // <1 pg/mL |
50 ul |
Quant |
96 wells |
| Interleukin
1 (beta) (mouse) |
EIA1604 |
15.6-1,000 pg/mL // <3 pg/mL |
50 uL |
Quant |
96 wells |
| Interleukin
1 (beta) (mouse) |
EIA3379 |
15, 16 - 1000 pg/ml |
50 ul serum, tissue culture
supernatant |
Quant |
192 wells |
| Interleukin
1 (beta) (mouse) Elisa |
EIA3302 |
15.16 - 1000 pg/ml |
50 ul Serum, tissue culture
supernatant |
Quant |
96 wells |
| Interleukin
1 (beta) (porcine) EIA |
EIA3181 |
39 - 2500 pg/ml |
50 ul serum, plasma, cell culture
medium |
Quant |
192 wells |
| Interleukin
1 (beta) (rat) |
EIA3541 |
25.6-2,500 pg/mL // < 12 pg/mL |
50 uL |
Quant |
96 wells |
| Interleukin
1 (beta) Elisa / CE |
EIA4437 |
24 - 1166 pg/ml //
2 pg/ml |
200 uL serum |
Quant |
96 wells |
| Interleukin
1 beta (porcine) EIA |
EIA3180 |
39 - 2500 pg / ml |
50 ul serum, plasma, cel culture
medium |
Quant |
96 wells |
| Interleukin
1 Receptor Antagonist (IL-1ra) Elisa |
EIA4500 |
31.2-2000 pg/ml //
4pg/ml |
100 ul serum, plasma, cell
culture |
Quant |
96 wells |
| Interleukin
10 |
EIA1609 |
10-500 pg/ml |
serum, plasma |
Quant |
96 wells |
| Interleukin
10 |
EIA4699 |
11-1335 pg/ml ///
1 pg/ml |
100 uL serum |
Quant |
96 wells |
| Interleukin
10 (mouse) |
EIA3380 |
31.2-2,000 pg/ml |
100 ul serum, plasma, cell
culture supernat |
Quant |
192 wells |
| Interleukin
10 (mouse) Elisa |
EIA3298 |
31.2-2,000 pg/ml |
100 ul Serum, Plasma, cell
culture supernat |
Quant |
96 wells |
| Interleukin
10 (porcine) EIA |
EIA3184 |
7.8 - 500 ul/ml |
serum, plasma,cell culture |
Quant |
96 wells |
| Interleukin
10 (porcine) EIA |
EIA3185 |
7.8 - 500 pg/ml |
Serum, plasma,cell culture |
Quant |
192 wells |
| Interleukin
10 (rat) Elisa |
EIA3166 |
0-2000 pg/ml |
100ul Serum, Plasma |
Quant |
192 wells |
| Interleukin
10 (rat) Elisa |
EIA4773 |
15.6 - 1000 pg/ml /// 1.47 pg/ml |
cell culture supernatants, human
serum |
Quant |
96 wells |
| Interleukin
12 +p40 Elisa |
EIA4698 |
15 - 1300 pg/ml ///
1.5 pg/ml |
100 ul serum |
Quant |
96 wells |
| Interleukin
12 p70 (rat) Elisa |
EIA4001 |
7.8 - 500 pg/ml / <2.5 pg/ml |
100 ul cell extract |
Quant |
96 wells |
| Interleukin
13 (human) Elisa |
EIA3410 |
|
|
|
192 wells |
| Interleukin
13 (rat) |
EIA3391 |
7.8 - 500 pg/mL // 1.5 pg/mL |
serum, plasma |
Quant |
192 wells |
| Interleukin
13 (rat) Elisa |
EIA3411 |
|
|
Quant |
96 wells |
| Interleukin
15 (human) |
EIA3392 |
|
|
Quant |
96 wells |
| Interleukin
15 (human) Elisa |
EIA3412 |
|
|
Quant |
192 wells |
| Interleukin
16 (human) |
EIA3393 |
|
|
Quant |
96 wells |
| Interleukin
16 (human) Elisa |
EIA3413 |
|
|
|
192 wells |
| Interleukin
18 (human) |
EIA4061 |
15.6 - 1000 pg/mL , 12.5 pg/mL |
100 uL serum, plasma, cell
culture supernat |
Quant |
96 wells |
| Interleukin
18 (rat) |
EIA4002 |
15.6 - 1000 pg/ml /
< 4pg/ml |
100 ul serum, plasma, cell
culture med |
Quant |
96 wells |
| Interleukin
18 (rat) |
EIA4059 |
15,6 - 1000pg/mL < 4 pg/mL |
100 ul serum, plasma, cell
culture med |
Quant |
192 wells |
| Interleukin
2 |
EIA0064 |
0.17 units/ml |
|
Quant |
96 wells |
| Interleukin
2 (mouse) |
EIA1605 |
50-2000 pg/ml |
serum |
Quant |
96 wells |
| Interleukin
2 (mouse) |
EIA3163 |
15 1000 pg/ml |
50ul Serum, Plasma |
Quant |
192 wells |
| Interleukin
2 (mouse) Elisa |
EIA3155 |
15 - 1000 pg/ml |
50ul Serum, Plasma |
Quant |
96 wells |
| Interleukin
2 (rat) |
EIA3381 |
|
|
Quant |
192 wells |
| Interleukin
2 (rat) |
EIA3407 |
23.4 - 1500 pg/mL //
<5pg/mL |
50 uL serum, cell culture |
Quant |
96 wells |
| Interleukin
2 Elisa / CE |
EIA4436 |
0.78 - 23.8 U/ml //
0.05 U/ml |
100 uL serum |
Quant |
96 wells |
| Interleukin
3 (human) Elisa |
EIA3289 |
|
10 ul Serum, plasma, cell culture
supernatant |
Quant |
96 wells |
| Interleukin
3 (human) Elisa |
EIA3408 |
|
|
Quant |
192 wells |
| Interleukin
3 (mouse) |
EIA3383 |
7.8 - 500 pg/mL /
<3 pg/mL |
50 ul serumcell culture |
Quant |
192 wells |
| Interleukin
4 (mouse) |
EIA1607 |
10-500 pg/ml |
serum, plasma |
Quant |
96 wells |
| Interleukin
4 (mouse) |
EIA3384 |
15.6 - 1000 pg/ml |
50 ul serum tissue culture
supernatant |
Quant |
192 wells |
| Interleukin
4 (mouse) Elisa |
EIA3291 |
15.6 - 1000 pg/ml |
50 ul Serum tissue culture
supernatant |
Quant |
96 wells |
| Interleukin
4 (porcine) |
EIA4091 |
0 - 1000 pg/mL // 2 pg/mL |
50 ul serum, plasma, cell culture
med |
Quant |
192 wells |
| Interleukin
4 (rat) |
EIA3385 |
|
|
|
192 wells |
| Interleukin
4 Elisa / CE |
EIA4435 |
14.5 - 1696 pg/ml //
1.2 pg/ml |
100 uL serum |
Quant |
96 wells |
| Interleukin
5 (mouse) |
EIA3396 |
7.8 - 500 pg/mL /
<3pg/mL |
serum, plasma |
Quant |
192 wells |
| Interleukin
5 (mouse) |
EIA3401 |
|
|
|
96 wells |
| Interleukin
6 (human) |
EIA1200 |
7 pg/mL |
serum or plasma |
Quant |
96 wells |
| Interleukin
6 (mouse) |
EIA1608 |
25-1000 pg/ml |
serum |
Quant |
96 wells |
| Interleukin
6 (mouse) |
EIA3386 |
|
|
|
192 wells |
| Interleukin
6 (mouse) Elisa |
EIA3403 |
7.8 - 500 pg/mL //
<3 pg/mL |
50 ul serum, plasma |
Quant |
96 wells |
| Interleukin
6 (rat) Elisa |
EIA3294 |
31.2 - 2,000 pg/ml |
50 ul Serum, tissue culture
supernatant |
Quant |
96 wells |
| Interleukin
6 Elisa / CE |
EIA4640 |
23,3 - 2560 pg/ml ///
2 pg/ml |
100 ul serum |
Quant |
96 wells |
| Interleukin
6 Titerzyme (human) |
EIA0979 |
4.1 pg/ml |
serum, cell culture |
Quant |
96 wells |
| Interleukin
6R hs (human soluble) |
EIA4423 |
62,5 - 4000 pg/ml //
<8 pg/ml |
20 ul serum / plasma |
Quant |
96 wells |
| Interleukin
7 (human) Elisa |
EIA3295 |
15.6 - 1,000 pg/ml |
100 ul serum, tissue culture
supernatant |
Quant |
96 wells |
| Interleukin
8 (porcine) EIA |
EIA3182 |
31.2 - 2000 pg / ml |
50 ul Serum, plasma |
Quant |
96 wells |
| Interleukin
8 (porcine) EIA |
EIA3183 |
31.2 - 2000 pg/ml |
50 ul serum, plasma |
Quant |
192 wells |
| Interleukin
8 Elisa |
EIA4700 |
7-750 pg/ml ///
0.7 pg/ml |
100 uL serum |
Quant |
96 wells |
| Interleukin-1
alpha (human) Elisa |
EIA4839 |
1.6 - 100 pg/mL
/// 1.06 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-1
beta (rat) Elisa |
EIA4911 |
31.25-2000 pg/mL ///
4.4 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-12
(mouse) Elisa |
EIA4920 |
31.25 - 2000 pg/mL ///
3.96 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-12p70
(human) Elisa |
EIA4843 |
3.2 - 200 pg/mL ///
2.11 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-12p70
(mouse) Elisa |
EIA4842 |
15.6 - 1000 pg/mL ///
<10.0 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-13
(human) Elisa |
EIA4841 |
1.56 - 100 pg/mL ///
0.73 pg/mL |
cell culture, serum, plasma
amniotic |
Quant |
96 wells |
| Interleukin-17
A (human) Elisa |
EIA4840 |
1.6 - 100 pg/mL ///
0.5 pg/mL |
50 uL cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-2
Receptor (human) Elisa |
EIA4835 |
0.31-20 ng/mL ///
0.27 ng/mL |
50 ul Cell culture, serum,
plasma, urine |
Quant |
96 wells |
| Interleukin-23
(human) Elisa |
EIA5058 |
78 - 5000 pg/mL ///
10 pg/mL |
50 ul cell culture supernatant,
serum |
Quant |
96 wells |
| Interleukin-5
(human) Elisa |
EIA4832 |
7.8 - 500 pg/mL ///
1.45 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-6
(porcine) Elise |
EIA1869 |
125 - 4000 pg/mL ///
-- |
100 ul serum |
Quant |
96 wells |
| Interleukin-6
(rat) Elisa |
EIA4845 |
31.3 - 2000 pg/mL ///
12 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| Interleukin-6
Receptor (human) Elisa |
EIA4844 |
8-500 ng/mL ///
0.01 ng/mL |
50 ul cell culture, serum,
plasma, amniotic |
Quant |
96 wells |
| Japanese
Encephalitis IgG (JE) Elisa |
EIA4518 |
- //
99 % |
4 ul serum (dilution 1:300) |
Qual |
96 wells |
| Jo-1 IgG |
EIA2787 |
|
serum, 10uL |
SemiQuant |
96 wells |
| Jo-1,
anti- Elisa |
EIA3581 |
|
|
Quant |
96 wells |
| Kilham
Virus (rat) EcoElisa |
EIA4976 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Kilham
Virus (rat) EcoElisa |
EIA4977 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| L1-CAM
Elisa |
EIA5074 |
8.75 - 280 ng/ml ///
0.1 ng/ml |
50 ul serum |
Quant |
96 wells |
| Lactoferrin,
anti- Elisa |
EIA3602 |
|
|
Quant |
96 wells |
| Lactoglobulin
= beta-Lactoglobulin IgA |
EIA4302 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| Lactoglobulin
= beta-Lactoglobulin IgG Elisa |
EIA4294 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| LC -
Anti-LC-1 Elisa |
EIA4276 |
0-300U/ ml // 1.0 U/ml |
10 ul serum, plasma (1:101
diluted) |
Quant |
96 wells |
| LDL ox
EIA (oxidased low density lipoporteins) (sandwich) |
EIA3430 |
|
|
Quant |
96 wells |
| LDL ox
Elisa (competitive) |
EIA4261 |
0.5 - 9.7 U/l / < 0.3 U/l |
50 ul serum (1:41 diluted) |
Quant |
96 wells |
| Legionella
IgG/IgM/IgA |
EIA2814 |
|
serum: 10uL |
Qual |
96 wells |
| Leishmania
Ab Canine Elisa |
EIA4796 |
neg. / pos. control |
|
Qual |
96 wells |
| Leptin
(human) (Sandwich EIA) |
EIA2395 |
2 - 100 ng/ml //
1.0 ng/ml |
15 ul serum, plasma |
Quant |
96 wells |
| Leptin
(mouse) Elisa |
EIA4564 |
0.2, 0.5, 1, 2, 5, 10, 20, 30
ng/ml //0.05 ng |
25 or 50ul serum, plasma |
Quant |
96 wells |
| Leptin
(mouse/rat) Elisa |
EIA4551 |
100 - 4000 pg / ml / 0.15 ng/ml |
7 ul serum, plasma and tissue
culture |
Quant |
96 wells |
| Leptin
(rat) |
EIA3115 |
56 - 3600 pg/ml //
46.7 pg/mL |
100 uL biological fluids |
Quant |
96 wells |
| Leptin
(rat) Elisa |
EIA4607 |
0.2 - 30 ng/ml //
0.04 ng/ml |
10 ul serum, plasma |
Quant |
96 wells |
| Leptin
Receptor Elisa human |
EIA3527 |
2 - 100 ng/ml ///
1.2 ng/ml |
50 ul serum, plasma/ tissure
culture |
Quant |
96 wells |
| Leptospira
Hardjo antibodies, MCA based, cattle |
EIA2498 |
Positive and Negative Control |
|
|
96 wells |
| Leukotriene
B4 Elisa (LTB4) Parameter Assay Kit |
EIA3088 |
7.8 - 2,000 pg/ml |
10 ul plasma, urine or tissue
homogate |
Quant |
96 wells |
| LH
(Lutenizing Hormone) serum |
EIA1289 |
10-200 mIU/ml |
serum |
Quant |
96 wells |
| LH
(Lutenizing Hormone) urine |
EIA1290 |
10-200 mIU/ml |
urine |
Quant |
96 wells |
| LH (Lutenizing
Hormone-Releasing Hormone) |
EIA1174 |
0.02-0.05 ng/mL |
serum |
Quant |
96 wells |
| LIF-HILDA |
EIA3878 |
300 - 3500 pg/mL 20pg/mL |
100 ul |
Quant |
96 wells |
| Lipase
(pancreatic h-p-Lipase) Elisa |
EIA4459 |
10 - 400 U/L / 5
U/L |
25 uL serum |
Quant |
96 wells |
| Lipoprotein
(a) Lp (a) |
EIA4406 |
1 - 165 mg/dL //
/ |
100 ul serum, plasma (diluted
1:500) |
Quant |
96 wells |
| LKM -
Anti-LKM-1 Elisa |
EIA4277 |
0-300U/ ml // 1.0 U/ml |
10 ul serum, plasma (1:101)
diluted) |
Quant |
96 wells |
| Lymphoc.
Choriomeningitis V. (guinea pig) EcoElisa |
EIA4982 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Lymphoc.
Choriomeningitis V. (guinea pig) EcoElisa |
EIA4983 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Lymphoc.
Choriomeningitis V. (hamster) EcoElisa |
EIA4984 |
pos. + neg. control ///
- |
50 uL 1;60 dil. serum |
Qual |
48 wells |
| Lymphoc.
Choriomeningitis V. (hamster) EcoElisa |
EIA4985 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Lymphoc.
Choriomeningitis V. (mouse) EcoElisa |
EIA4978 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Lymphoc.
Choriomeningitis V. (mouse) EcoElisa |
EIA4979 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Lymphoc.
Choriomeningitis V. (rat) EcoElisa |
EIA4980 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Lymphoc.
Choriomeningitis V. (rat) EcoElisa |
EIA4981 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Lypocheck
Immunoassay tri-level control |
EIA2979 |
|
|
|
12x5ml |
| Lysozyme
anti- Elisa |
EIA3601 |
|
|
Quant |
96 wells |
| Malaria
Ab Elisa |
EIA5048 |
pos. + neg. control ///
>95 % |
150 uL serum |
Qual |
192 wells |
| Malaria
Elisa |
EIA4263 |
neg. / pos. control,
qualitative // 92.5 - 100 % |
50 ul serum, plasma |
Qual |
96 wells |
| MBL
Oligomer Elisa |
EIA5057 |
2 - 4000 ng/mL ///
0.02 ng/mL |
5 ul serum, plasma |
Quant |
96 wells |
| MCP-1
(human) Elisa |
EIA4857 |
16 - 1000 pg/mL ///
2.31 pg/mL |
100 ul cell culture, serum,
plasma, amniotic |
Quant |
96 wells |
| MCP-1
(mouse) Elisa |
EIA5091 |
15.6 - 1000 pg/mL ///
2.2 pg/mL |
50 ul Cell culture supernatant,
serum |
Quant |
96 wells |
| MCP-1
(rat) Titerzyme (Monocyte Chemoattractant Protein 1) |
EIA3620 |
|
|
Quant |
96 wells |
| MCP-1
(rat), (Monocyte Chemoattractant Protein 1) |
EIA4072 |
11.7-650 pg/mL, < 0.8 pg/mL |
50 ul serum/ plasma/cell culture |
Qual |
192 wells |
| Measles
IgG |
EIA3495 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Measles
IgM |
EIA3496 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Melatonin |
EIA1431 |
2.6 pg/ml |
serum or plasma |
Quant |
96 wells |
| Melatonin
(direct) Saliva Elisa |
SLV4779 |
0.5 - 50 pg/mL ///
0.3 pg/mL |
100 ul Saliva |
Quant |
96 wells |
| Melatonin
Sulfate |
EIA1432 |
1 ng/ml |
urine |
Quant |
96 wells |
| Meningitis
IgG Elis |
EIA4918 |
pos./neg control ///
--- |
10 ul serum/plasma |
Qual |
96 wells |
| Met
Combi Plasma Elisa |
EIA4865 |
Metan 40-5275 pg/mL, Normetan:
33-5906 |
300 ul plasma |
Quant |
2 x 96 wells |
| Metanephrine |
EIA2748 |
26-2500 ug/L //
8.6 ug/L |
10 ul urine |
Quant |
96 wells |
| Metanephrine
Plasma Elisa |
EIA4313 |
15-3,000pg/ml //
7.5pg/ml |
plasma |
Quant |
96 wells |
| Metanephrine
urine Elisa |
EIA4315 |
15 - 1,500ng/ml // 7.5ng/ml |
urine |
Quant |
96 wells |
| MetCombi
plasma Methanephrine/Normetanephrine |
EIA4082 |
norm: 0-10000 pg/ml, meth: 0-6000
pg/ml |
500 ul plasma |
Quant |
2 x 96 wells |
| MetCombi
Elisa (Methanephrine/Normetanphrine) |
EIA4083 |
norm 0-6000ng/ml,
meth:0-2000ng/ml |
10 ul urine |
Quant |
2 x 96 wells |
| Microalbumin |
EIA2361 |
|
|
Quant |
96 wells |
| Microalbumin Elisa |
EIA3881 |
0.15 - 400 ug/ml 0.5 ug/ml |
20 ul urine |
Quant |
96 wells |
| Microglobulin
Alpha-1 |
EIA5100 |
0.019-1.5 mg/l ///
0.006 mg/l. |
10 ul serum, plasma, urine |
|
96 wells |
| Microglobulin,
(anti-beta2) Elisa |
EIA3609 |
|
|
Quant |
96 wells |
| Microglobulin,
(beta-2) |
EIA1789 |
0.2 ug/ml |
serum |
Quant |
96 wells |
| Milk
stabilisation kit incl. sterile test tubes (bovine) |
EIA3162 |
|
|
|
50 tests |
| Minute
Virus (mouse) EcoElisa |
EIA4986 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Minute
Virus (mouse) EcoElisa |
EIA4987 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| MIP-1
beta (human) (Macrophage Inflam Protein-1b) |
EIA3788 |
15.6-1000 pg/ml 2pg/ml |
50 ul |
Quant |
96 wells |
| MIP-2
(rat) (Macrophage Inflammatory Protein-2) |
EIA3789 |
10-640 pg/ml <1pg/ml |
50 ul |
Quant |
96 wells |
| MIP-5
(human) (Macrophage Inflammatory Protein-5) |
EIA3790 |
7.8-500 pg/ml < 1 pg/ml |
10 ul (1:20) |
Quant |
96 wells |
| MMP-13
(human) Elisa |
EIA4862 |
0.31 - 20 ng/mL /// 0.18 ng/mL |
50 ul dil. cell culture
supernatant, serum |
Quant |
96 wells |
| MMP-9
(human) Elisa |
EIA4861 |
0.23 - 15 ng/mL ///
0.05 ng/mL |
10 ul dil. cell culture
supernatant, serum |
Quant |
96 wells |
| Morphine
(serum/blood) Elisa |
EIA4923 |
1 - 100 ng/ml ///
- |
10 ul serum, whole blood |
Quant |
96 wellsq |
| Morphine
(serum/blood) Elisa |
EIA4924 |
1-100 ng/ml ///
- |
10 ul serum, whole blood |
Quant |
480 wells |
| Morphine
(urine) Elisa |
EIA4925 |
5-100 ng/ml ///
/ |
10 ul urine |
Quant |
96 wells |
| Morphine
(urine) Elisa |
EIA4926 |
5-100 ng/ml ///
- |
10 ul urine |
Quant |
480 wells |
| MPO
(Myeloperoxidase human) |
EIA4165 |
0.0 - 12.5 ng/ml // 0.13 ng/ml |
100 ul biolog. fluids |
Quant |
96 wells |
| MPO
(Myeloperoxidase) Elisa |
EIA4571 |
3 - 300 ug/l //
< 3 ug/l |
25 ul serum / plasma |
Quant |
96 wells |
| MPO
(Myeloperoxidase) IgG (pANCA) |
EIA2776 |
|
serum, 10uL |
SemiQuant |
96 wells |
| MPO
(pANCA) anti- Elisa |
EIA3597 |
|
|
Quant |
96 wells |
| MSH
(alpha) (Melanocyte Stimulating Hormone) |
EIA2951 |
|
|
Quant |
96 wells |
| Mumps
IgG |
EIA3497 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Mumps
IgM |
EIA3498 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Mycoplasma
hominis IgA |
EIA5097 |
neg., pos. cutoff control |
10 uL serum |
Qual |
96 wells |
| Mycoplasma
hominis IgA Elisa |
EIA5053 |
pos. / neg./ cut-off control ///
- |
10 ul serum ///
n.d. |
Qual |
96 wells |
| Mycoplasma
hominis IgG Elisa |
EIA4559 |
pos./neg. / cut-off control |
10 ul serum, plasma |
Qual |
96 wells |
| Mycoplasma
IgG (ref. sera opt., price on req.) |
EIA2812 |
|
serum: 10ul |
Qual |
96 wells |
| Mycoplasma
IgM (ref. sera opt., price on req.) |
EIA2813 |
|
serum: 10uL |
Qual |
96 wells |
| Mycoplasma
pneumoniae IgG |
EIA3499 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Mycoplasma
pneumoniae IgM |
EIA3500 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Mycoplasma
pulmonis (hamster) EcoElisa |
EIA4992 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Mycoplasma
pulmonis (hamster) EcoElisa |
EIA4993 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Mycoplasma
pulmonis (mouse) EcoElisa |
EIA4988 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Mycoplasma
pulmonis (mouse) EcoElisa |
EIA4989 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Mycoplasma
pulmonis (rat) EcoElisa |
EIA4990 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Mycoplasma
pulmonis (rat) EcoElisa |
EIA4991 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Myoglobin |
EIA3955 |
12 to 90ng/ml //
5ng/ml |
serum and plasma |
Quant |
96 wells |
| Neopterin |
EIA2949 |
|
|
|
96 wells |
| Neopterin
Elisa |
EIA1476 |
|
|
Quant |
96 wells |
| Neopterin
Elisa |
EIA4366 |
1.35 - 111 nmol/L //
0.32 nmol/L |
10 ul serum |
Quant |
480 wells |
| NGAL
(human) Elisa neutrophil gelatinase lipocalin |
EIA5083 |
approx 10-1000 pg/ml ///
4 pg/ml |
10 ul tissue fluids |
Quant |
96 wells |
| NGAL
(rat) Elisa |
EIA5055 |
0.05 - 5 U/ml ///
0.009 U/ml |
10 ul urine, serum, plasma,
tissue extracts |
Quant |
96 wells |
| NGAL
Rapid (human) Elisa neutrophil
gelatinase lipocalin |
EIA4893 |
0, 0.2, 2, 5, 10, 20 ng/ml ///
<0.1 ng/mL |
10 ul urine, plasma or serum |
|
96 wells |
| Nitric
Oxide (total) Assay kit |
EIA3639 |
|
|
|
96 wells |
| Nitric
Oxide Assay Kit (Colorimetric Nitric Oxide) |
EIA3638 |
|
|
|
2 x 96 wells |
| Noradrenalin
(Norepinephrine) |
EIA2049 |
5-500 ng/ml |
20 ul urine (extraction) |
Quant |
96 wells |
| Noradrenalin
Research Elisa |
EIA4706 |
8 - 2048 pg/sample /// 2.7 pg/sample |
1-100 uL tissue extracts,
dialysates |
Quant |
96 wells |
| Noradrenaline
Elisa |
EIA4317 |
4-1,024mg/ml // urine: 2ng/ml,
plasma: 67pg/ml |
plasma, urine |
Quant |
96 wells |
| Normetanephrine
plasma Elisa |
EIA4319 |
30 - 6,000 pg/ml // 15pg/ml |
plasma |
Quant |
96 wells |
| Normetanephrine
urine Elisa |
EIA4321 |
40-4,000ng/ml // 20ng/ml |
urine |
Quant |
96 wells |
| Normethanephrine |
EIA2749 |
77-7500 ug/L //
12 ug/L |
10 ul Urine |
Quant |
96 wells |
| Norovirus
(stool) Elisa |
EIA4864 |
neg. and pos. control ///
93.3 |
100 ul or 50 -100 mg stool |
Qual |
96 wells |
| NSE |
EIA4424 |
5 - 200 ug/L //
1ug/L |
25 uL serum |
Quant |
96 wells |
| NSE
(Neuron specific Enolase) (controls extra EIA4458) |
EIA2353 |
|
|
Quant |
96 wells |
| NSE
Elisa (controls included) |
EIA4610 |
4 - 100 ng/mL //
4 ng/mL. |
25 uL serum |
Quant |
96 wells |
| NT-proBNP
direct Elisa |
EIA4827 |
10-640 fmol/ml ///
3 fmol/ml |
50 ul serum, plasma |
Quant |
96 wells |
| Opiates
(serum/blood) Elisa |
EIA4927 |
5 - 500 ng/ml ///
- |
25 ul serum, whole blood |
Quant |
96 wells |
| Opiates
(serum/blood) Elisa |
EIA4928 |
5 - 500 ng/ml ///
- |
25 ul serum, whole blood |
Quant |
480 wells |
| Opiates
(urine) Elisa |
EIA4922 |
50-1000 ng/ml ///
--- |
25 ul urine |
Quant |
480 wells |
| Opiates
(urine) Elisa |
EIA4929 |
50 - 1000 ng/ml ///
- |
25 ul urine |
Quant |
96 well |
| Osteocalcin
(mouse) |
EIA4010 |
1 - 50 ng/ml, quantit / |
5-10 ul serum |
Quant |
96 wells |
| Osteocalcin
(rat) |
EIA2095 |
|
|
Quant |
96 wells |
| Osteocalcin
intact (human) |
EIA1735 |
0.78 ng/ml |
Plasma |
Quant |
96 wells |
| Osteocalcin
intact EIA |
EIA3375 |
2-90 pg/ml |
25 ul serum, plasma |
Quant |
96 wells |
| Osteocalcin
mid-tact, (human) |
EIA1733 |
0.4 ng/ml |
Serum or Plasma |
Quant |
96 wells |
| Osteopontin
(human) (OPN) |
EIA3116 |
2 - 32 ng/mL //
0.11 ng/mL |
100 uL cuture fluids, urine,
breast milk |
Quant |
96 wells |
| Osteopontin
(mouse) Elisa |
EIA4933 |
1 - 64 ng/ml ///
0.15 ng/ml |
100 ul urine, EDTA plasma and
cell culture |
Quant |
96 wells |
| Osteopontin
(mouse, and rat) |
EIA3557 |
|
|
Quant |
96 wells |
| Osteopontin
(rat) Elisa |
EIA4934 |
0.07 - 4.75 ng/ml ///
0.01 ng/ml |
100 ul urine, EDTA plasma and
cell culture |
Quant |
96 wells |
| Osteoprotegerin
(human) Elisa |
EIA4573 |
1.5 - 60 pmol/l // 0.13 pmol/l |
50 ul serum, plasma, synovial
fluid |
Quant |
96 wells |
| Osteoprotegerin
(OPG) |
EIA3551 |
|
|
Quant |
96 wells |
| Ovalbumin
IgA Elisa |
EIA4295 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| Ovalbumin
IgG |
EIA4296 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| Ovarian
(anti-Ovarian Ab) |
EIA2937 |
n/a |
serum |
Quant |
96 wells |
| Ovarian
Ab Ig-Typing Elisa |
EIA3777 |
|
|
Quant |
96 wells |
| Oxytocin
Elisa |
EIA3117 |
3.9-1000 pg/mL // 4.68 pg/mL |
100 uL tissue cultures media |
Quant |
96 wells |
| p27,
human p27 (p27Klp1) |
EIA4491 |
25 - 1,600 pg/mL //
10.8 pg/mL |
100 uL total cell lysates |
Quant |
96 wells |
| P38 MAPK
(total) |
EIA4003 |
31.2 - 2000 pg/ml /
16 pg/ml |
100 ul cell extract |
Quant |
96 wells |
| P38 MAPK
[pTpY180/182] Elisa |
EIA4004 |
1.6 - 100 U/ml /
0.8 U/ml |
100 ul cell extract |
Quant |
96 wells |
| p53
total human Elisa |
EIA4632 |
125 - 8000 pg/mL //
<50 pg/mL |
10 ul Serum, plasma, cell culture |
Quant |
96 wells |
| P-ANCA,
Elisa |
EIA2579 |
|
|
|
96 wells |
| Pancreatic
Peptide Elisa |
EIA4639 |
0-100 ng/ml ///
/ |
50 ul plasma |
Quant |
96 wells |
| Pankrin
Elisa |
EIA3781 |
|
|
Quant |
96 wells |
| PAP
(Prostatic Acid Phosphate) |
EIA1566 |
1-30 ng/ml |
serum |
Quant |
96 wells |
| PAP
Complex (Plasmin alpha-2 Antiplasmin Complex) |
EIA3763 |
50 - 5000 ug/l / 50
ug/l |
plasma 50 ul |
Quant |
192 wells |
| PAP
micro 2000 Elisa |
EIA5084 |
50-2000 ug/L ///
10 ug/L |
50 ul plasma |
Quant |
192 wells |
| PAPP-A - 60
Elisa |
EIA4889 |
2.0 - 60.0 ug/ml ///
0.034 ug/ml |
20 ul serum, plasma |
Quant |
96 wells |
| PAPP-A
(human) <EIA2397(a)> |
EIA2397 |
1.0 - 30.0 ug/ml ///
0.133 ug/ml |
10 ul serum, plasma |
Quant |
96 wells |
| PAPP-A
US (ultra sensitive) Elisa |
EIA4512 |
11.25 - 450 ng/ml /
0.023 ng/ml |
100 ul serum |
Quant |
96 wells |
| Parainfluenza
1,2,3 IgA - |
EIA3871 |
pos./neg./cut-off control //
>90 % |
10 uL serum |
Qual |
96 wells |
| Parainfluenza
1/2/3 IgA, Elisa |
EIA4351 |
pos./neg. control // - |
100 ul serum, plasma (diluted
1:101) |
Qual |
96 wells |
| Parainfluenza
1/2/3 IgG Elisa |
EIA4349 |
pos./neg. control // - |
100 ul serum, plasma (diluted
1:101) |
Qual |
96 wells |
| Parainfluenza
1/2/3 IgM, Elisa |
EIA4350 |
pos./neg control // - |
100 ul serum, plasma (diluted
1:101) |
Qual |
96 wells |
| Parainfluenza
3 (PI3) Bovine Elisa |
EIA4429 |
pos. samples; qualitative test |
10 ul bovine serum |
Qual |
96 tests |
| Parainfluenza
Virus-5 (PI5) IgG antibodies (canine) |
EIA2491 |
Positive and Negative Control |
100 ul Serum (3-fold diluted,
1:30 - 1:810) |
|
96 wells |
| Parietal
cell, anti- Elisa |
EIA3607 |
|
|
Quant |
96 wells |
| Parvovirus
B 19 IgG |
EIA3503 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Parvovirus
B 19 IgM |
EIA3504 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Parvovirus
IgG (w/o controls) |
EIA4328 |
|
|
Quant |
96 wells |
| Parvovirus
IgM (w/o controls) |
EIA4329 |
|
|
Quant |
96 wells |
| Parvovirus-1
(mouse) EcoElisa |
EIA4994 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Parvovirus-1
(mouse) EcoElisa |
EIA4995 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Parvovirus-1
(rat) EcoElisa |
EIA4996 |
pos. + neg. control ///- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Parvovirus-1
(rat) EcoElisa |
EIA4997 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Pepsinogen
I Elisa |
EIA4604 |
3 - 300 ng/ml
/// 0.5 ng/ml |
25 ul serum |
Quant |
96 wells |
| Pepsinogen
II Elisa |
EIA4603 |
6.3 - 100 ng/ml ///
0.5 ng/ml |
50 ul serum |
Quant |
96 wells |
| PGF2-alpha
(8-iso-PGF2-alpha ) |
EIA3080 |
6.1 - 100,000 pg/mL // 16.3 pg/mL |
100 uL biological fluids |
Quant |
96 wells |
| Phenylalanine
(PKU) neonatal Screening Assay |
ENZ4743 |
1 - 18 mg/dL ///
- |
newborn's heel blood |
Quant |
2400 wells |
| Phenylalanine
(PKU) neonatal Screening Assay |
ENZ4502 |
1 - 18 mg/dL //
- |
newborn's heel blood |
Quant |
480 wells |
| Phenylalanine
(with Membrane Plate) |
EIA1479 |
0.2 mg/dL |
blood |
Quant |
960 wells |
| Phenylalanine
(without Membrane Plate) |
EIA1480 |
0.2 mg/dl. |
blood |
Quant |
960 tests |
| Phenylalanine
neonate (with Membrane Plate) |
EIA1477 |
0.2 mg/dL |
blood |
Quant |
192 wells |
| Phenylalanine
neonate (without Membrane Plate) |
EIA1478 |
0.2 mg/dL |
blood |
Quant |
192 wells |
| Phosphatidic
Acid IgG/IgM, anti Elisa |
EIA3594 |
|
|
Quant |
96 wells |
| Phosphatidyl
Inositol IgG/IgM, anti- Elisa |
EIA3593 |
|
|
Quant |
96 wells |
| Phosphatidyl
Serine Ab IgG/IgM, Elisa |
EIA2580 |
|
|
|
96 wells |
| Phosphatidyl
Serine IgG/IgM, anti- Elisa |
EIA3592 |
|
|
Quant |
96 wells |
| Phospho-ERK
1/2 Elisa |
EIA4178 |
62.5-2,000 pg/mL // 46.5 pg/mL |
100 ul cell lysis matrices and
buffers |
Quant |
96 wells |
| Phospholipid
Screen IgG/IgM, anti- Elisa |
EIA3591 |
|
|
Quant |
96 wells |
| PIIANP
Elisa (Type IIA Collagen N-Propeptide) |
EIA4446 |
4.69 - 150 ng/ml //
1.076 ng/ml |
50 ul serum |
Quant |
96 wells |
| PLGF
(Placenta like growth factor) |
EIA4529 |
0-1000 pg/ml //
2,258 pg/ml |
urine / serum |
Quant |
96 wells |
| PLTP
Acitivity (Plasma phospholipid transfer protein) |
EIA4415 |
yes /
- |
1 - 3 ul serum / plasma |
Qual |
100 tests |
| PMN
Elastase (human) Elisa |
EIA4856 |
0.156-10 ng/mL ///
1.98 ng/mL |
5/10 ul (1:100 dil.) cell cult.,
plasma |
Quant |
96 wells |
| PMSG
(Pregnant Mare Serum Gonadotropin) |
EIA1298 |
On Request |
serum |
Quant |
96 wells |
| Pneumonia
Virus (guinea pig) EcoElisa |
EIA5002 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Pneumonia
Virus (guinea pig) EcoElisa |
EIA5003 |
pos. + neg. control |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Pneumonia
Virus (hamster) EcoElisa |
EIA5004 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Pneumonia
Virus (hamster) EcoElisa |
EIA5005 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Pneumonia
Virus (mouse) EcoElisa |
EIA4998 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Pneumonia
Virus (mouse) EcoElisa |
EIA4999 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Pneumonia
Virus (rat) EcoElisa |
EIA5000 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Pneumonia
Virus (rat) EcoElisa |
EIA5001 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Pneumonitis
Virus (mouse) EcoElisa |
EIA5006 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Pneumonitis
Virus (mouse) EcoElisa |
EIA5007 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Polio
Virus (mouse) EcoElisa |
EIA5008 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Polio
Virus (mouse) EcoElisa |
EIA5009 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 Wells |
| Polio
Virus (rat) EcoElisa |
EIA5010 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Polio
Virus (rat) EcoElisa |
EIA5011 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Polyoma
Virus (mouse) EcoElisa |
EIA5012 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Polyoma
Virus (mouse) EcoElisa |
EIA5013 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| PR3
IgG (CANCA) (Proteinase-3) |
EIA2778 |
|
serum, 10uL |
SemiQuant |
96 wells |
| Pregnenolon
Serum Elisa |
EIA4912 |
0.1 - 25.6 ng/ml ///
0.054 ng/ml |
50 ul serum |
Quant |
96 wells |
| Pregnenolone |
EIA4170 |
0,1 - 25,6 ng/ml // 0.05 ng/ml |
50 ul serum |
Quant |
96 wells |
| Progesterone |
CLA4656 |
0.1 - 60 ng/ml |
25 ul serum |
Quant |
96 wells |
| Progesterone |
EIA1561 |
0.3-20 ng/ml |
serum |
Quant |
96 wells |
| Progesterone |
SLV2931 |
10 - 5000 pg/ml //
5.5 pg/ml |
25 ul saliva |
Quant |
96 wells |
| Progesterone
(serum) CLA |
CLA4663 |
|
serum |
Quant |
96 wells |
| Progesterone
/ 17a Hydroxy-Progesterone (serum) CLA |
CLA4665 |
|
serum |
Quant |
96 wells |
| Progesterone,
17 a-Hydroxy- |
EIA1292 |
0.15-20 ng/ml |
serum (saliva) |
Quant |
96 wells |
| Progesterone,
17 a-Hydroxy- (salivary) |
SLV3140 |
5 - 5000 pg/ml //
3 pg/ml |
25 ul saliva |
Quant |
96 wells |
| Proinsulin
intact (Control sera lyophilized, 2 x 1 ml included) |
EIA1560 |
2-100 pmol/L |
serum, plasma |
Quant |
96 wells |
| Proinsulin
total (human) |
EIA4156 |
2 - 200 pM / 0.5 pM |
20 ul serum and plasma |
Quant |
96 wells |
| Prolactin |
CLA4729 |
5-200 ng/ml ///
0.3 ng/ml |
25 ul serum` |
Quant |
96 wells |
| Prolactin |
EIA1291 |
5-200 ng/ml |
serum |
Quant |
96 wells |
| Prolactin
(rat) Elisa |
EIA4493 |
2.25 - 180 ng/ml //
0.36 ng/ml |
10 uL serum / plasma |
Quant |
96 wells |
| Prostacyclin
(urinary Prostacycline) |
EIA3108 |
|
|
Quant |
96 wells |
| Prostaglandin
(6-keto) F1 (alpha) |
EIA3078 |
|
|
Quant |
96 wells |
| Prostaglandin
E1 |
EIA3092 |
|
|
Quant |
96 wells |
| Prostaglandin
E2, High Sensitivity |
EIA3097 |
|
|
Quant |
96 wells |
| Prostaglandin
E2, High Sensitivity |
EIA3525 |
|
|
Quant |
480 wells |
| Prostaglandin
F2 (alpha) |
EIA3101 |
|
|
Quant |
96 wells |
| Prostaglandin
J2, 15-deoxy- 12,14-, correlate EIA |
EIA3640 |
|
|
Quant |
96 wells |
| Prostaglandin
J2, 15-deoxy-, Correlate-EIA |
EIA3540 |
|
|
Quant |
480 wells |
| Protein
A |
EIA1823 |
<1pg/ml / 13.6 pg/ml |
serum |
Quant |
96 wells |
| Prothrombin
IgG, anti- Elisa |
EIA3613 |
|
|
Quant |
96 wells |
| Prothrombin
IgG/IgM, anti- Elisa |
EIA3612 |
|
|
Quant |
96 wells |
| Prothrombin
Screen, anti- |
EIA3614 |
|
|
Quant |
96 wells |
| PSA
(Prostate Specific Antigen) |
EIA1778 |
0.5 ng/ml |
serum |
Quant |
96 wells |
| PSA
(Prostate Specific Antigen) |
EIA4105 |
|
|
Quant |
96 wells |
| PSA free |
EIA1792 |
0.05 ng/ml |
serum |
Quant |
96 wells |
| PSA free |
EIA4189 |
0.75 - 12 ng/ml /
0.1 nng/ml |
25ul serum |
Quant |
96 wells |
| PSA
total |
EIA3719 |
1.56 - 25 ng/ml / 0.5 ng/ml |
25 ul |
Quant |
96 wells |
| PSA,
Total |
EIA3945 |
|
|
Quant |
96 wells |
| PSA,
Total (Prostate Specific Antigen) |
CLA4657 |
0.005 - 100 ng/ml ///
0.002 ng/ml |
50 ul serum |
Quant |
96 wells |
| PTH
Intact (Parathyroid Hormone) |
EIA3645 |
.9 pg/ml |
human serum |
Quant |
96 wells |
| PTH
intact (rat) Elisa |
EIA4935 |
25-840 pg/ml ///
1.6 pg/ml |
25 ul serum plasma or cell
culture |
Quant |
96 wells |
| PTH-RP
(1-34) (human, rat, mouse) Elisa |
EIA4757 |
0-100 ng/ml ///
- |
50 ul plasma |
Quant |
96 wells |
| Rabies
IgG (dog) Ab, virus |
EIA2486 |
Positive and Negative Control |
|
|
96 wells |
| Rabies
IgM (dog) Ab, virus |
EIA2487 |
Positive and Negative Control |
|
Qual |
96 wells |
| Rabies
Virus (dog) Ag, Nucleo |
EIA2490 |
Positive and Negative Control |
|
|
96 wells |
| Rabies
Virus Ag, Glycoprotein |
EIA2489 |
Positive and Negative Control |
|
|
96 wells |
| RANTES
(rat) |
EIA3785 |
39-2500 pg/ml < 20 pg/ml |
25 ul |
Quant |
192 wells |
| Reovirus
Type 3 (guinea pig) EcoElisa |
EIA5018 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Reovirus
Type 3 (guinea pig) EcoElisa |
EIA5019 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Reovirus
Type 3 (hamster) EcoElisa |
EIA5020 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Reovirus
Type 3 (hamster) EcoElisa |
EIA5021 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Reovirus
Type 3 (mouse) EcoElisa |
EIA5014 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Reovirus
Type 3 (mouse) EcoElisa |
EIA5015 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Reovirus
Type 3 (rat) EcoElisa |
EIA5016 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Reovirus
Type 3 (rat) EcoElisa |
EIA5017 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Resistin
(human) |
EIA4194 |
0,16 - 10 ng/ml 0,16 ng/ml |
20 ul serum/plasma |
Quant |
96 wells |
| Resistin
(human) Elisa |
EIA4945 |
0.016 - 1 ng/ml ///
- |
100 ul plasma, serum, culture
media, tissue |
Quant |
96 wells |
| Resistin
(human) Elisa |
EIA4572 |
1 - 50 ng/ml //
0.033 ng/ml |
10 ul serum, plasma and tissue
culture |
Quant |
96 wells |
| Resistin
(mouse) |
EIA4283 |
0.78 - 50 ng/ml //
0.78 ng/ml |
10 ul serum, plasma, adipocyte
extracts |
Quant |
96 wells |
| Resistin
(mouse) |
EIA4554 |
1 - 100 ng/ml //
5 pg/ml |
10 ul serum, plasma and tissues |
Quant |
96 wells |
| Resistin
(rat) Elisa |
EIA4550 |
0.25 - 20 ng / ml //
0.05ng/ml |
10 ul serum and tissue culture
media |
Quant |
96 wells |
| Retinol
binding Protein (RBP) Elisa |
EIA4391 |
1/1 - 33 ug/l // 0.9 ug/l |
20 ul plasma, serum; 100 ul urine |
Quant |
96 wells |
| RF IgA
(Rheumatoid Factor), Elisa |
EIA3586 |
|
|
Quant |
96 wells |
| RF IgG
(Rheumatoid Factor), Elisa |
EIA3584 |
|
|
Quant |
96 wells |
| RF
IgG/IgM/IgA (Rheumatoid Factor Screen)
Elisa |
EIA3583 |
|
|
Quant |
96 wells |
| RF IgM
(Rheumatoid Factor) |
EIA2775 |
|
serum, 10 uL |
SemiQuant |
96 wells |
| RF IgM
(Rheumatoid Factor), Elisa |
EIA3585 |
|
|
Quant |
96 wells |
| Rib-P,
anti- Elisa |
EIA3582 |
|
|
Quant |
96 wells |
| RNP-70
Kd, anti- Elisa |
EIA3579 |
|
|
Quant |
96 wells |
| Rotavirus/
EDIM (mouse) EcoElisa |
EIA5022 |
pos. + neg. control /// - |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Rotavirus/
EDIM (mouse) EcoElisa |
EIA5023 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| RSV IgA
(Respiratory syncytial virus) |
EIA3506 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| RSV IgG
(Respiratory syncytial virus) |
EIA3507 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| RSV IgM
(Respiratory syncytial virus) |
EIA3508 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Rubella
IgG |
EIA1800 |
|
serum |
Quant |
96 wells |
| Rubella
IgG quant. |
EIA3510 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Quant |
96 wells |
| Rubella
IgM |
EIA1801 |
|
serum |
Quant |
96 wells |
| Rubella
IgM |
EIA3511 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| S100
Elisa (not incl. controls,: order EIA4458) |
EIA4556 |
50 - 3500 ng/L //
<10 ng/L |
50 uL serum |
Quant |
96 wells |
| S100B
(human) Elisa |
EIA4555 |
50 - 2000 pg/ml //
5 pg/ml |
60 ul serum,plasma and tissue
culture |
Quant |
96 wells |
| SALI-TUBES
100 |
SLV4158 |
|
|
|
100 t. |
| SALI-TUBES
500 |
SLV4157 |
|
|
|
500 t. |
| Saliva
Control |
SLV4576 |
|
|
|
3 x 2 ml |
| sApo1/FAS
(human) Elisa |
EIA4854 |
16-1000 pg/mL ///
13.2 pg/mL |
50 ul cell culture, serum, plasma |
Quant |
96 wells |
| sCD23
(human) Elisa |
EIA4833 |
12.5 - 400 U/mL ///
6.789 U/mL |
100 ul cell culture, serum,
plasma |
Quant |
96 wells |
| sCD30
(human) Elisa |
EIA4849 |
1.6 - 100 ng/mL ///
0.33 ng//mL |
25 ul cell culture, serum, plasma |
Quant |
96 wells |
| sCD40
(human) Elisa |
EIA4850 |
8 - 500 pg/mL ///
7.92 pg/mL |
50 ul cell culture supernatant |
Quant |
96 wells |
| sCD40
Ligand (human) Elisa |
EIA4852 |
0.16 - 10 pg/mL ///
0.062 pg/mL |
20 ul cell culture, serum, plasma |
Quant |
96 wells |
| sCD40
Ligand (human) high sensitive Elisa |
EIA4851 |
0.08 - 5.0 ng/mL ///
0.01 ng/mL |
20 ul cell culture, serum and
plasm |
Quant |
96 wells |
| sCD44
(human) Elisa |
EIA4876 |
0.12-4ng/m. ///
0.015 ng/mL |
10 ul cell culture, other body
flui |
Quant |
96 wells |
| Schistosoma
IgG |
EIA3512 |
pos. / neg. control // - |
100 ul serum (diluted 1:40) |
|
96 wells |
| Scl-70,
anti- Elisa |
EIA3580 |
|
|
Quant |
96 wells |
| Secretory
IgA (sIgA) Elisa |
EIA4601 |
22.2 - 600 ng/ml //
13.4 ng/ml |
10 ul saliva + 100 mg stool |
Quant |
96 wells |
| Sendai
Virus (guinea pig) EcoElisa |
EIA5028 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Sendai
Virus (guinea pig) EcoElisa |
EIA5029 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Sendai
Virus (hamster) EcoElisa |
EIA5030 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Sendai
Virus (hamster) EcoElisa |
EIA5031 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Sendai
Virus (mouse) EcoElisa |
EIA5024 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Sendai
Virus (mouse) EcoElisa |
EIA5025 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Sendai
Virus (rat) EcoElisa |
EIA5026 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
49 wells |
| Sendai
Virus (rat) EcoElisa |
EIA5027 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Serotonin |
EIA1300 |
0.14-33 ng/ml |
plasma or urine |
Quant |
96 wells |
| Serotonin |
EIA3947 |
15-2500 ng/ml // 7.5 ng/ml serum,
Urin 3ng /ml |
10 ul Serum, Urin, 25 ul Plasma |
Quant |
96 wells |
| Serotonin
FAST Elisa |
EIA5061 |
15-2500 ng/ml ///
5 ng/mL |
25 ul serum, urine and platelets |
Quant |
96 wells |
| Serotonin
Research (ultra sensitive) |
EIA4642 |
2-333 pg /// 1 pg |
20 ul tissue homogenates,
dialysates |
Quant |
96 wells |
| sE-Selectin
Elisa |
EIA4775 |
1.6 - 50 ng/ml ///
0.33 ng/mL |
20 uL serum, plasma, cell culture |
Quant |
96 wells |
| sFAS
Ligand (human) Elisa |
EIA4855 |
0.16 - 10 ng/mL ///
0.07 ng/mL |
50 ul cell culture, serum,
plasma, amniotic |
Quant |
96 wells |
| sGP130/sCD130
(human) Elisa |
EIA4768 |
56.25 - 1800 pg/mo ///
<15 pg/ml |
100 ul cell culture
supernatants,serum |
Quant |
96 wells |
| SHBG
(Sex Hormone Binding Globulin) IEMA |
EIA2996 |
4 - 260 nmol/l //
0.2 nmol/l |
25 uL serum / plasma |
Quant |
96 wells |
| sICAM-1
(human) |
EIA4781 |
6.25 - 100 ng/ml - ///
2.17 ng/mL |
10 uL cell cult. supern., serum,
plasma, urine, |
Quant |
96 wells |
| Simian
Virus 5 (guinea pig) EcoElisa |
EIA5032 |
pos. + neg. control ///
- |
50 uL 1:60 dil serum |
Qual |
48 wells |
| Simian
Virus 5 (guinea pig) EcoElisa |
EIA5033 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Simian
Virus 5 (hamster) EcoElisa |
EIA5034 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Simian
Virus 5 (hamster) EcoElisa |
EIA5035 |
pos. + neg. control ///
- |
50 uL 1:60 dil serum |
Qual |
96 wells |
| SLE
(anti-Nucleosomes) Elisa |
EIA3610 |
|
|
Quant |
96 wells |
| sL-selectin
human Elisa |
EIA4875 |
0.39-25ng/ml ///
0.19 ng/mL |
5 ul cell culture supernatant |
Quant |
96 wells |
| Sm
anti-, Elisa |
EIA3577 |
|
|
Quant |
96 wells |
| Sm IgG |
EIA2784 |
|
serum, 10 uL |
SemiQuant |
96 wells |
| Sm RNP
IgG |
EIA2785 |
|
serum, 10uL |
SemiQuant |
96 wells |
| Sm RNP,
anti-RNP Elisa |
EIA3578 |
|
|
Quant |
96 wells |
| Soya IgA
Elisa |
EIA4300 |
pos. and neg. control |
10 ul serum, plasma (1:100
diluted) |
Qual |
96 wells |
| Soya IgG
Elisa |
EIA4299 |
pos. and neg. control |
10 ul serum, plasma (1:100
dilutes |
Qual |
96 wells |
| sp185
(HER-2) human Elisa |
EIA4877 |
0.16-10ng/ml ///
0.06 ng//mL |
15 ul cell culture supernatant |
Quant |
96 wells |
| Sperm Ab
Ig-Typing Elisa |
EIA4878 |
31-250 U/mL ///
--- |
5 uL serum |
Quant |
96 wells |
| Sperm
Antibody |
EIA1826 |
62-500 U/ml |
serum |
Quant |
96 wells |
| Sperm
Antibody |
EIA4249 |
31 - 250 U/ml ///
- |
50ul
dil. seminal plasma |
Quant |
96 wells |
| sPJ-selectin
human, Elisa |
EIA4874 |
2.19-140 ng/ml ///
1.06 ng/mL |
10 ul cell culture supernatant |
Quant |
96 wells |
| sPLA2
Activity kit (secretory Phospholipase
A2) |
EIA3636 |
|
|
|
96 wells |
| sRANKL
(free) human Elisa |
EIA4771 |
0.4 - 40 pmol/l ///
0.2pmol/l |
5 ul serum / plasma |
Quant |
96 wells |
| sRANKL
(total) human Elisa |
EIA4772 |
0.4 - 64 pmol/l ///
0.1pmol/l |
5 ul serum / plasma |
Quant |
96 wells |
| SS-A
(Ro) IgG |
EIA2782 |
|
serum, 10 uL |
SemiQuant |
96 wells |
| SS-A
(Ro), anti- Elisa |
EIA3573 |
|
|
Quant |
96 wells |
| SS-A 52,
anti- Elisa |
EIA3574 |
|
|
Quant |
96 wells |
| SS-A 60,
anti- Elisa |
EIA3575 |
|
|
Quant |
96 wells |
| SSB (La)
IgG |
EIA2783 |
|
serum, 10 uL |
SemiQuant |
96 wells |
| SS-B
(La), anti- Elisa |
EIA3576 |
|
|
Quant |
96 wells |
| Substance
P |
EIA3120 |
|
|
Quant |
96 wells |
| Substance
P (human - rat - mouse) |
EIA1634 |
0.02-0.05 ng/ml |
plasma |
Quant |
96 wells |
| Survivin
(total) human |
EIA4137 |
31.25-1,000 pg/mL //
10.4 pg/mL |
100 uL biolog. fluids |
|
96 wells |
| sVCAM-1
human Elisa |
EIA4873 |
3.2-100 ng/ml ///
0.59 ng/mL |
10 uL cell culture supernatant |
Quant |
96 wells |
| Syphilis
(anti-TP) (double antigen sandwich method) |
EIA4131 |
|
|
Qual |
96 wells |
| Syphilis
(Treponema pallidum) Ab |
EIA3798 |
|
|
Quant |
96 wells |
| Syphilis
Ab Screen (min. order 10 kits) |
EIA4405 |
pos. / neg. control, qualit. //
100 % |
10 ul serum; plasma |
Qual |
192 wells |
| T-3
(Triiodothyronine) |
EIA1780 |
0.2 ng/ml |
serum |
Quant |
96 wells |
| T-3,
Free |
EIA2385 |
|
|
|
96 wells |
| T-3,
total Elisa |
EIA4569 |
0.5 - 10.0 ng/ml //
0.1 ng/ml |
50 ul serum |
Quant |
96 wells |
| T-3,
Uptake |
EIA3267 |
15.0 - 46.0 % U / .. |
25 ul serum or plasma |
Quant |
192 wells |
| T-4 |
EIA1781 |
0.4 ug/dl |
serum |
Quant |
96 wells |
| T-4
(canine) |
EIA2492 |
Positive and Negative Control |
|
|
96 wells |
| T-4
Canine (dog) Rapid EIA |
EIA3441 |
|
|
|
32 wells |
| T-4
feline (cat) Rapid EIA |
EIA3442 |
|
|
|
32 wells |
| T-4,
free |
CLA4659 |
2 - 120 pg/ml /// 1 pg/ml |
50 ul serum |
Quant |
96 wells |
| T-4,
Free |
EIA2386 |
|
|
|
96 wells |
| T-4,
Free |
EIA4109 |
|
|
Quant |
192 wells |
| T-4,
total Elisa |
EIA4568 |
- /
10 nmol/L |
10 ul serum |
Quant |
96 wells |
| Taenia
Solium IgG (cysticercosis) |
EIA3513 |
pos. / neg. control //
88 % |
100 ul serum (diluted 1:64) |
Qual |
96 wells |
| TBEV IgG
(tick borne encephalitis virus) (FSME) |
EIA3515 |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| TBEV IgM
(tick borne encephalitis virus) (FSME) |
EIA3516 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Testosterone |
EIA1559 |
0.2-16 ng/ml |
serum, plasma |
Quant |
96 wells |
| Testosterone |
SLV3013 |
10 - 5000 pg/ml //
1.9 pg/mL |
100 ul saliva |
Quant |
96 wells |
| Testosterone
(serum) CLA |
CLA4662 |
|
serum |
Quant |
96 wells |
| Testosterone,
(Dihydro-) ELISA |
EIA2330 |
6 pg/ml |
serum, plasma |
Quant |
96 wells |
| Testosterone,
(Dihydrotestosterone) |
EIA4132 |
|
|
Quant |
96 wells |
| Testosterone,
free |
CLA4660 |
0.25 - 100 pg/ml ///
0.17 pg/ml |
25 ul serum |
Quant |
96 wells |
| Testosterone,
Free |
EIA2924 |
0.15 pg/ml |
serum / plasma |
Quant |
96 wells |
| Testosterone,
Saliva |
CLA4661 |
2 - 800 pg/ml /// 1.0 pg/ml |
100 ul saliva |
Quant |
96 wells |
| Tetanus
toxin IgG (quant.) |
EIA3514 |
2 x pos control (0.5+5 IU/ml)/ 1
x neg control |
10 ul serum (1+100 diluted) |
Quant |
96 wells |
| TGF beta
1 (human) (Transforming Growth Factor) |
EIA1864 |
20 - 600 pg/ml; 10pg/ml
sensitivity |
serum/plasma |
Quant |
96 wells |
| TGF beta
2 (human) (Transfornimg Growth Factor) |
EIA2396 |
|
|
Quant |
96 wells |
| ThromboCombo
IgG / IgM |
EIA3883 |
IgG: 0-100U/mL, IgM: 0-100
U/ml --- |
10 ul serum or plasma |
Quant |
96 wells |
| Thromboxane
B2 |
EIA3105 |
|
|
Quant |
96 wells |
| Thyroglobulin |
EIA4126 |
|
|
Quant |
96 wells |
| Thyroglobulin
Ab |
EIA3708 |
0 - 9000 IU/ml / 10 IU/ml |
10 ul serum plasma |
Quant |
96 wells |
| Thyroglobulin
anti- |
EIA1613 |
on request |
serum |
Quant |
96 wells |
| Thyroglobulin
Anti-Thyroglobulin |
EIA4110 |
|
|
Quant |
96 wells |
| Thyroglobulin
Elisa |
EIA3377 |
|
|
Quant |
96 wells |
| Thyroglobulin
IgG |
EIA2792 |
|
serum, 10uL |
Qual |
96 wells |
| TIMP-1
Elisa (Tissue Inhibitor of Matrix Metalloproteinase-1) |
EIA3782 |
1.56-25 ng/ml < 1ng/ml |
50 uL serum, plasma, cell culture |
Quant |
192 wells |
| TM-CA125
Elisa |
EIA5072 |
will follow ///
will follow |
|
Quant |
96 wells |
| TM-CA15.3
Elisa |
EIA5068 |
will follow ///
will follow |
|
Quant |
96 wells |
| TM-CA19.9
Elisa |
EIA5069 |
will follows ///
will follow |
|
Quant |
96 wells |
| TM-CA72.4
Elisa |
EIA5071 |
will follow ///
will follow |
|
Quant |
96 wells |
| TM-CYFRA21.1 |
EIA5070 |
3 - 50 ng/ml ///
0.15 ng/ml |
50 ul serum, plasma |
Quant |
96 wells |
| TNF
(alpha) (rat) |
EIA4774 |
39 - 2500 pg/ml ///
11.2 pg/ml |
50 ul cell cultures
supernatants,serum |
Quant |
96 wells |
| TNF
alpha (human) (Tumor Necrosis Factor ) |
EIA0976 |
8.3 pg/ml |
serum, plasma, cell culture |
Quant |
96 wells |
| TNF
alpha (mouse) (Tumor Necrosis Factor) |
EIA1568 |
25-1000 pg/ml |
serum |
Quant |
96 wells |
| TNF
alpha (mouse) Elisa |
EIA3158 |
19.5 - 1250 pg/mL // <3 pg/mL |
50 ul serum, plasma |
Quant |
96 wells |
| TNF
alpha (mouse) Elisa |
EIA3167 |
19-2000 pg/ml |
50ul Serum, Plasma |
Quant |
192 wells |
| TNF
alpha (porcine) |
EIA3186 |
15.6 - 1000 pg/ml |
50 ul serum, plasma, cell culture
samples |
Quant |
96 wells |
| TNF
alpha (porcine) |
EIA3187 |
15.6 - 1000 pg/ml |
50 ul serum, plasma, cell culture
samples |
Quant |
192 wells |
| TNF
alpha (rat) (Tumor Necrosis Factor) Sensitive |
EIA3543 |
|
|
Quant |
96 wells |
| TNF
alpha (rat) Elisa |
EIA2358 |
15-1000 pg/ml |
50ml Serum, Plasma |
Quant |
96 wells |
| TNF
alpha (rat) Elisa |
EIA3168 |
15 1000 plg/ml |
50ml Serum, Plasma |
Quant |
192 wells |
| TNF
alpha Elisa / CE |
EIA4641 |
7-518 pg/ml ///
0.7 pg/ml |
200 ul serum |
Quant |
96 wells |
| Toolan's
H-1 Virus (rat) EcoElisa |
EIA5036 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
48 wells |
| Toolan's
H-1 Virus (rat) EcoElisa |
EIA5037 |
pos. + neg. control ///
- |
50 uL 1:60 dil. serum |
Qual |
96 wells |
| Toxocara
Canis IgG |
EIA3518 |
pos. / neg. control //
93.3 % |
100 ul serum (diluted 1:64) |
Qual |
96 wells |
| Toxoplasma
gondii IgA Elisa |
EIA3683 |
|
serum |
Quant |
96 wells |
| Toxoplasma
gondii IgG (quantitative) |
EIA3519 |
20 - 200 IU/ml + neg. control |
10 ul serum (1+100 diluted) |
Quant |
96 wells |
| Toxoplasma
gondii IgM |
EIA3520 |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Toxoplasma
IgG (TORCH) |
EIA1798 |
|
serum |
Quant |
96 wells |
| Toxoplasma
IgM (TORCH) |
EIA1799 |
|
serum |
Quant |
96 wells |
| TPO
(Thyroid Peroxidas) Anti-TPO |
EIA4114 |
|
|
Quant |
96 wells |
| TPO
(Thyroid Peroxidase) anti- Elisa |
EIA3561 |
33 - 3000 IU/mL //
5 IU/mL |
10 ul serum / plasma |
Quant |
96 wells |
| TPO IgG
(Thyroid Peroxidase) |
EIA2791 |
|
serum, 10uL |
Qual |
96 wells |
| TPS
CYK18 Cytokeratin (Tissue Polypeptide Specific Ag) |
EIA2354 |
|
|
Quant |
96 wells |
| TRAIL
(human) Elisa |
EIA4009 |
46.8 - 3000 pg/ml - quant. / <20 pg/ml |
100 ul cell extract |
Quant |
96 wells |
| Transferrin
Receptor (sTfR) human Elisa (Soluble) |
EIA4256 |
0.2 - 10 ug/mll // 0.1 ug/ml |
30 ul serum, plasma and culture
medium |
Quant |
96 wells |
| Transglutaminase
IgA, anti- |
EIA3611 |
|
|
Quant |
96 wells |
| Transglutaminase
IgA, anti- ELISA |
EIA3152 |
positive and negative Reference
sera |
100 ul serum ( 1:250 diluted) |
Qual |
96 wells |
| Transglutaminase
IgG, anti-tissue |
EIA3882 |
1U/ml |
10 ul serum or plasma |
Quant |
96 wells |
| Transglutaminase
Screen, anti-tissue Elisa |
EIA4464 |
5 - 200 U/ml //
1 U/ml |
10 ul serum / plasma |
Quant |
96 wells |
| Treponema
Pallidum IgG (Syphilis IgG) |
EIA3517 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Treponema
Pallidum IgM (Syphilis) |
EIA4267 |
pos. / neg. control |
10 ul serum (1+100 diluted) |
Qual |
96 wells |
| Treponema
pallidum Screen |
EIA5054 |
neg., pos. cut-off control ///
n.d. |
20 uL serum, plasma |
Qual |
96 wells |
| Treponema
Pallidum Screen IgG/IgM Elisa |
EIA4697 |
pos. / neg./ cut-off control ///
- |
100 ul Serum, Plasma |
Qual |
96 wells |